Exzitotoxizität im ZNS bei Mausmutanten mit veränderten Glutamatrezeptoren by Coserea, Irinel Andreea
 DISSERTATION
submitted to the
Combined Faculties for the Natural Sciences and for Mathematics
of the Ruperto-Carola University of Heidelberg, Germany
for the degree of
Doctor of Natural Sciences
 presented by
Biologist Irinel Andreea Coserea
born in Bucharest, Romania
oral examination: 3.03.2005
Exzitotoxizität im ZNS bei
Mausmutanten mit
veränderten Glutamatrezeptoren
Gutachter:    Prof. Dr. Hannah Monyer
Prof. Dr. Peter Seeburg
11.INTRODUCTION............................................................................................................................................................... 3
1.1 Preface ................................................................................................................................................................... 3
1.2 Signal transmission in the central nervous system ................................................................................................. 3
1.3 Excitatory and inhibitory synaptic transmission .................................................................................................... 5
1.4 Ionotropic glutamate receptors .............................................................................................................................. 6
1.4.1 Classification of ionotropic glutamate receptors ................................................................................................ 6
1.4.2 Sructure of ionotropic glutamate receptors......................................................................................................... 6
1.4.3 The Q/R/N site of ionotropic glutamate receptors............................................................................................... 7
1.4.4 Subunit stoichiometry .......................................................................................................................................... 8
1.5 The NMDA receptor ............................................................................................................................................... 8
1.5.1 Role of the NMDA receptor during synaptic transmission .................................................................................. 8
1.5.2 Modulation and pharmacology of NMDAR channel function ............................................................................. 9
1.5.3 NMDAR subunits and splice variants................................................................................................................ 10
1.5.4 Developmental profile of NMDAR subunits and effect on kinetics.................................................................... 10
1.5.5 The C-terminal tail of the NMDAR.................................................................................................................... 13
1.5.6 Mice expressing C-terminally truncated NR2 subunits ..................................................................................... 14
1.5.6 NMDAR subunits and synaptic plasticity .......................................................................................................... 15
1.5.7 NMDARs and disease ........................................................................................................................................ 16
1.6 Excitotoxic cell death ........................................................................................................................................... 16
1.6.1 Basic characteristics.......................................................................................................................................... 16
1.6.2 Mechanism of excitotoxicity .............................................................................................................................. 17
1.6.3 Clinical trials..................................................................................................................................................... 18
1.6.4 Role of the NR1 subunit in excitotoxicity........................................................................................................... 18
1.6.5 Role of the NR2 subunits in excitotoxicity ......................................................................................................... 19
1.7 The aim of this study............................................................................................................................................. 20
2. MATERIALS AND METHODS ........................................................................................................................................ 21
2.1 Cell culture ........................................................................................................................................................... 21
2.1.1 Plates preparation ............................................................................................................................................. 21
2.1.2 Dissection .......................................................................................................................................................... 21
2.1.3 Enzymatic digestion of the cortex ...................................................................................................................... 22
2.1.4 Plating the cells ................................................................................................................................................. 23
2.1.5 Feeding and maintenance of neuronal cultures ................................................................................................ 23
2.1.6 Reagents and solutions ...................................................................................................................................... 23
2.2 Neuronal toxicity experiments .............................................................................................................................. 24
2.3 Assessment of neuronal injury.............................................................................................................................. 24
2.3.1 LDH assay ......................................................................................................................................................... 24
2.3.2 Trypan blue dye exclusion ................................................................................................................................. 25
2.4 Mouse genotyping................................................................................................................................................. 25
2.5 Immunocytochemistry........................................................................................................................................... 26
2.6 Colocalization analysis ........................................................................................................................................ 27
2.7 45Ca analysis......................................................................................................................................................... 27
2.8 Immunoblot analysis............................................................................................................................................. 28
2.9 Electrophysiological recordings........................................................................................................................... 28
2.9.1 Somatic recordings............................................................................................................................................ 29
2.9.2 Synaptic recordings ........................................................................................................................................... 29
3. RESULTS...................................................................................................................................................................... 30
3.1 Introduction .......................................................................................................................................................... 30
3.2 The cortical cell culture system and excitotoxicity ............................................................................................... 30
3.3 Excitotoxicity in NR1-/- cortical cultures .............................................................................................................. 33
3.4 NMDA-induced toxicity in gene-manipulated cultures......................................................................................... 34
3.4.1 NMDA-induced toxicity in NR2ADC/DC cultures ................................................................................................. 35
3.4.2 NMDA-induced toxicity in the NR2B DC/DC cultures........................................................................................... 44
23.5 NMDA-induced toxicity in wild-type cultures ...................................................................................................... 50
3.5.1 NMDA-induced toxicity in the presence of the NR2B subunit-specific antagonist............................................ 51
3.5.2 NMDA-induced toxicity in the presence of the NR2A subunit-specific antagonist............................................ 53
4. DISCUSSION................................................................................................................................................................. 57
4.1 NMDA receptor subtypes in excitotoxicity ........................................................................................................... 57
4.1.1 In NR2ADC/DC cultures excitotoxicity is mediated via NR1/NR2B containing NMDA receptors ........................ 59
4.1.2 No NMDA-mediated excitatory cell death in neuronal NR2BDC/DC cultures...................................................... 60
4.1.3 In wild-type cultures excitotoxicity is mediated by NR2A and NR2B containing NMDA receptors .................. 61
4.2 NMDA receptor localization and excitotoxicity ................................................................................................... 63
4.3 Ca2+ influx, intracellular signaling and excitotoxicity ......................................................................................... 64
4.4 From molecular interactions to clinical treatments ............................................................................................. 65
4.5 NMDA subunits antagonits and clinical trials ..................................................................................................... 66
4.6 Ischemia – still a challenge .................................................................................................................................. 67
5. ABBREVIATIONS.......................................................................................................................................................... 68
6.REFERENCES ................................................................................................................................................................ 72
Introduction
3
1.Introduction
1.1 Preface
The great challenge of neural science is to elucidate the mechanism by which humans act, perceive,
learn and remember. Nerve cells and their connectivity in the brain accomplish all of these processes.
In order to understand how the brain integrates and stores perceptions, it is fundamental to study the
mechanisms of neuronal signaling and also how connections between neurons are formed and
modified by experience. Furthermore, a big challenge is to elucidate the mechanisms that might
contribute to the pathogenesis of human central neuronal cell loss induced by acute insults such as
hypoxia-ischemia, hypoglycemia, sustained epilepsy and brain trauma.
1.2 Signal transmission in the central nervous system
The central nervous system (CNS) consists of two major classes of cells: nerve cells (neurons) and
glial cells (glia). The human brain contains 1011 neurons and 10x more glia. The traditional view is
that glia provide structure to the brain, sometimes insulate neuronal groups and synaptic connections
from each other. Certain classes of glia cells guide the migration of the neurons and direct the
outgrowth of the axons. Furthermore, glia help to form the blood-brain barrier, remove cellular
debris and secrete trophic factors. However, this view of glia acting only as support cells has recently
been challenged. Recent studies suggest that glia respond to action potentials with a rise in
intracellular Ca2+ (Dani et al., 1992), that they have the ability to modulate synaptic strength (Araque
et al., 1998; Parpura and Haydon, 2000) and even that they are able to release neurotransmitter
(Innocenti et al., 2000).
Nevertheless, the majority of fast signaling is mediated by neurons, which are classically divided into
two functional classes: principal (or projection) neurons and interneurons. Neurons have a highly
polarized structure consisting of the cell body (soma), dendrites for receiving signals from other
neurons, the axon, which projects to target cells, and presynaptic terminals for neurotransmitter
release at synapses with targets. Nerve cells transmit signals either electrically by directly
exchanging ions via gap junctions (electrical synapses) or chemically by neurotransmitter release at
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the specialized sites of contact with other neurons (chemical synapses). These chemical synapses
consist of the presynaptic axon terminal and the postsynaptic dendrite or soma.
Nerve cells are able to transmit signals because of their ability to generate an action potential, a
regenerative electrical signal, which spreads along the axon actively without attenuation. Generation
of the action potential takes place in the axon hillock, which is the initial segment of the axon; the
axon thus plays the role of the output element of the neuron, whereas the dendrites are input
elements. However, the finding that following initiation, action potentials actively backpropagate
into the dendrites, providing a retrograde signal of neuronal output to the dendritic tree, has extended
the notion of dendrites as being input units (Stuart and Sakmann, 1994; Yuste and Tank, 1996;
Johnston et al., 1996). Briefly, action potentials are mediated by sequential opening of voltage-
activated Na+ and K+ channels. Voltage gated Na+ channels have the highest open probability when
the membrane potential is depolarized to a threshold level. This results in further depolarization and
the membrane potential is driven toward the equilibrium potential for Na+ (around +50 mV). The
surrounding membrane, which also contains voltage-activated Na+ channels, is subsequently equally
depolarized resulting in a spread of the excitation. The inactivation of Na+ channels and the opening
of voltage-gated K+ channels terminate the action potential. The subsequent outflow of K+
repolarizes the membrane by restoring the initial charge distribution. When an action potential
arrives at the presynaptic terminal, it opens the voltage-dependent Ca2+ channels and the resulting
Ca2+ influx triggers neurotransmitter release from the presynaptic vesicles into the synaptic cleft. The
neurotransmitter diffuses across the synaptic cleft and binds to its postsynaptic receptors leading to
an opening or closing of the ion channels, thereby altering the membrane conductance and the
potential of the postsynaptic cell.
Receptors are divided into two classes: ionotropic and metabotropic. Ionotropic receptors are
membrane proteins that contain an ion channel. In contrast, metabotropic receptors act indirectly by
activating a G-protein-coupled second messenger cascade that modulates channel activity. Whereas
ionotropic receptors mediate fast synaptic activity in the millisecond range, metabotropic receptors
mediate synaptic actions in the second-to-minute range, often associated with changes in neuronal
excitability and synaptic strength.
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1.3 Excitatory and inhibitory synaptic transmission
In the CNS, synaptic transmission can be either excitatory or inhibitory. Glutamate is the main
excitatory neurotransmitter in the vertebrate brain. After release from the nerve terminals, glutamate
crosses the synaptic cleft and activates three different types of ionotropic receptors: L-a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA)
receptors.
AMPA and kainate receptors are responsible for fast ionic inward current, thereby contributing to the
early peak of the excitatory postsynaptic potential (EPSP). NMDA receptor channels are blocked by
Mg2+ at resting membrane potential and are relieved from Mg2+ block when the membrane is
depolarized (Mayer et al., 1984; Nowak et al., 1984). Thus, under physiological ionic conditions,
both glutamate and depolarization of the membrane are necessary to open the NMDA receptor
channel. Since NMDAR channels activate and deactivate relatively slowly compared to non-
NMDAR channels, NMDA receptors contribute only to the late component of the EPSP.
Another class of glutamate receptors is represented by metabotropic receptors, which act on ion
channels via a cascade of second messengers. Whereas glutamate always has an excitatory effect via
ionotropic glutamate receptors (iGluRs), via metabotropic glutamate receptors (mGluRs) it can
produce either excitation or inhibition.
The main inhibitory transmitters in the CNS are g-Aminobutyric acid (GABA) and glycine. GABA
receptors are divided into ionotropic GABAA receptors and metabotropic G-protein coupled GABAB
receptors. GABAA receptors form Cl- permeable channels, which open upon binding of GABA,
thereby hyperpolarizing the membrane. Excitatory synapses are typically located on the dendrites
(often on protrusions called spines and more rarely directly on the shaft), whereas inhibitory
synapses can often be found on the soma and on the dendritic shafts. Thus, spatially and temporally
distinct excitatory and inhibitory signals (EPSPs and respectively IPSPs) will sum within a neuron
and be either sub- or suprathreshold for the generation of an action potential at the axon hillock.
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1.4 Ionotropic glutamate receptors
1.4.1 Classification of ionotropic glutamate receptors
The majority of excitatory neurotransmission in the brain is mediated by ionotropic glutamate
receptors. Ionotropic glutamate receptors (GluRs) are ligand-gated ion channels, which are
selectively permeable for cations, principally Na+, K+ and sometimes Ca2+ ions. Although the
majority of ionotropic GluRs is expressed in the central nervous system, there is evidence that
subpopulations exist in the pancreas (Inagaki et al., 1995), osteoclasts and osteoblasts (Chenu et al.,
1998), skin (Ault and Hildebrand, 1993) and cardiac ganglia (Gill et al., 1998). Numerous glutamate
receptor-like (GLR) genes have been identified in plant genomes, and plant GLRs are predicted, on
the basis of sequence homology, to retain ligand-binding and ion channel activity (Davenport, 2002).
On the basis of their responsiveness to certain glutamate derivatives, ionotropic GluRs are classified
as AMPA, NMDA and kainate receptors.
AMPA receptor (AMPAR) channels are heteromers of the GluR-A to GluR-D subunits, kainate
receptors are subdivided into GluR-5 to GluR-7, KA-1 and KA-2 (Hollmann and Heinemann, 1994;
Wisden and Seeburg, 1993), and the subfamilies of NMDA receptors (NMDARs) will be explained
in detail below. A fourth class of ionotropic GluR is represented by the d1 and d2 receptors which
share between 18 to 25 % sequence identity with the other GluR subunits. When expressed in a
heterologous system, they do not bind glutamate and do not form functional channels, neither alone
nor with other GluRs (Lomeli et al., 1993; Araki et al., 1993). However, they seem to play an
important role, since a point mutation in d2 receptors leads to the phenotype of “lurcher mice”, with
spontaneous degeneration of Purkinje cells and cerebellar ataxia (Zou et al., 1997).
1.4.2 Sructure of ionotropic glutamate receptors
Ionotropic GluRs share the same transmembrane topology, but differ in their pharmacological and
kinetic profile, ion permeability, expression patterns and trafficking. They typically consist of three
transmembrane domains (M1, M3, M4) and a re-entrant membrane loop (M2) (Fig.1). The N-
terminus is located on the extracellular side and controls proper assembly of receptor complexes
(Ayalon and Stern, 2001).
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Fig. 1: Schematic structure of an ionotropic glutamate receptor subunit
The three transmembrane domains M1, M3 and M4 are shown as gray boxes, the membrane loop M2 forms the channel
pore. The star indicates the position of key amino acids regulating the ion selectivity, e.g. the Q/R for AMPA, N for
NMDA receptors. S1 and S2 designate the two ligand-binding domains. The alternatively spliced flip/flop exon occurs in
AMPA receptor and is located extracellulary. Potential glycosilation sites are shown as trees in the N-terminal region
(Ayalon and Stern, 2001).
The carboxy-terminal (C-terminal) domain is located on the intracellular side. It influences receptor
function (Sprengel et al., 1998) and interacts with trafficking, motor, signaling and scaffolding
proteins, assuring proper receptor localization and regulation (Barry and Ziff, 2002). The agonist-
binding domain consists of two segments (S1 and S2) that are formed by the region preceding the
M1 domain and the loop between the M3 and M4 domain. The S1 and S2 lobes form a clamshell
structure that undergoes a conformational change to enclose the ligand upon binding (Stern-Bach et
al., 1994; Armstrong et al., 1998).
1.4.3 The Q/R/N site of ionotropic glutamate receptors
The Q/R/N site of the M2 segment is occupied by a glutamine (Q) or an arginine (R) residue in
AMPA and kainate receptors and by asparagine (N) in NMDA receptors. Site-selective RNA editing
(Sommer et al., 1991; Higuchi et al., 1993) of the GluR-B pre-mRNA results in an arginine residue
in 99 % of the GluR-B population, whereas the other three AMPAR subunits feature glutamine at
this site. Heteromeric AMPAR channels containing one GluR-B(R) subunit are impermeable to Ca2+
(Burnashev et al., 1992; Hume et al., 1991), demonstrating the dominance of GluR-B(R) in terms of
Ca2+ permeability.  In principal neurons most AMPAR channels are Ca2+-impermeable, whereas
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interneurons express Ca2+-permeable AMPAR channels. The Q/R/N site furthermore affects single
channel conductance, blockade by intracellular polyamines and permeation of anions (Hume et al.,
1991; Swanson et al., 1996; Ruppersberg et al., 1993). In the NMDAR, this critical channel site does
not only control Ca2+ permeability but also voltage-dependent block by Mg2+ and inhibition by
protons, Zn2+ and MK-801 (Burnashev et al., 1992; Kashiwagi et al., 1997; Sakurada et al., 1993).
1.4.4 Subunit stoichiometry
Functional and crystallographic studies show that GluR channels most probably consist of four
subunits assembled as a dimer-of-dimers (Premkumar and Auerbach, 1997; Rosenmund et al., 1998;
Laube et al., 1998; Sobolevsky et al., 2004). In the case of the NMDA receptors, each channel
contains two NR1 and two NR2 subunits (Behe et al., 1995; Sheng et al., 1994). The specific subunit
composition not only determines the biophysical characteristics of the GluR channel but also its
trafficking during basal transmission and synaptic plasticity (Barry and Ziff, 2002; Barria and
Malinow, 2002). For example, AMPA receptors assembled from GluR-B and GluR-C subunits are
constitutively delivered to the postsynaptic membrane, whereas delivery and insertion of GluR-A
and GluR-B heteromers is regulated by synaptic activity (Hayashi et al., 2000; Shi et al., 2001).
1.5 The NMDA receptor
1.5.1 Role of the NMDA receptor during synaptic transmission
During synaptic transmission, one of the most noticeable features of the NMDAR-mediated
component of the synaptic current is its slow rise and decay, compared with the much faster
AMPAR-mediated component. NMDAR channels are Ca2+-permeable and exhibit voltage-
dependent block by Mg2+. These properties make them key players in synaptic development,
synaptic plasticity and excitotoxic cell death. It is generally agreed that the glutamate concentration
rises rapidly to millimolar levels in the synaptic cleft with a time constant of about 1 ms. However,
NMDAR channels open roughly 10 ms after glutamate has been released and continue to open and
close repeatedly for several hundred milliseconds (Dzubay and Jahr, 1996; Behe et al., 1999). The
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slow decay time therefore reflects, in part, the high affinity of NMDARs, with glutamate generating
exceptionally prolonged channel activity until the transmitter molecules finally dissociate.
1.5.2 Modulation and pharmacology of NMDAR channel function
The NMDAR family appears unique among ligand gated ion channels and requires the binding of
both the transmitter (glutamate) and the coagonist (glycine) for its activation (Dingledine et al.,
1999). In addition, a variety of molecules present in the extracellular milieu bind to, or interact with
these receptors, influencing their behavior (Fig. 2).
Fig. 2: Schematic representation of the NMDA receptor complex
The NMDA receptor complex possess a glutamate recognition site to which receptor agonists and competitive
antagonists bind, as well as other binding sites for glycine, polyamines, Mg2+ and Zn2+. Channel opening permits an
influx of Na+ and Ca2+ ions, and an efflux of K+ ions (After Scatton, 1993).
Furthermore, at the cell’s resting membrane potential, Mg2+ ions bind to a site located deep within
the ion channel to occlude the flow of cations (Johnson and Ascher, 1990; Li-Smerin and Johnson,
1996). Activation of the channel requires depolarization in order to relieve the blockage by Mg2+
ions. NMDAR channels can be blocked pharmacologically by the competitive antagonist D-5-amino
phosphonate pentanoic acid or by the open channel blocker MK-801. The non-competitive
Poliamine site
K+ Zn2+ site
Glycine site
Extracellular side
Cytoplasmic side
Mg2+ site
Ca2+
Na+
Glutamate
recognition 
site
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antagonist ifenprodil acts through the proton sensor of the NR1 subunit and has an IC50
(concentration producing half-maximal inhibition) that is 400-fold lower for NR2A- than for NR2B-
containing receptors (Cull-Candy et al., 2001). Many of the important NMDAR properties are
influenced by the subunit composition of the receptor.
1.5.3 NMDAR subunits and splice variants
NMDARs are divided into three classes: the ubiquitously expressed NR1 subunit, a family of four
distinct NR2 subunits (A, B, C and D), and two NR3 subunits (A, B) (Hollmann, 1999; Moriyoshi et
al., 1991; Monyer et al., 1992,1994; Sugihara et al., 1992; Das et al., 1998). NR1 exists as eight
distinct isoforms owing to the presence of three independent sites of alternative splicing (Dingledine
et al., 1999). Similarly, each of the NR2 and NR3 subunits (apart from NR2A) has several splice
variants, although the functional relevance of the different splice variants remains unclear. To form a
functional NMDAR channel, NR1 and NR2 subunits are required (Dingledine et al., 1999; Meguro
et al., 1992; Monyer et al., 1992), with NR1 containing the binding site for the coagonist glycine and
NR2 containing the glutamate-binding site (Anson et al., 1998; Laube et al., 1998; Kuryatov et al.,
1994). The NR3 subunit can co-assemble with NR1/NR2 and seems to confer a modulatory function
on channel properties (Perez-Otano et al., 2001; Matsuda et al., 2002). NR3B-containing receptors
are not permeable to Ca2+ and show little of the Mg2+-dependent blockade that is characteristic of
NMDA receptors (Chatterton et al., 2002). Neurons have a large excess of the NR1 subunits relative
to NR2 subunits; this pool of NR1, which is unassembled with NR2, does not reach the cell surface
and is rapidly degraded (Chazot and Stephenson, 1997a; Huh and Wenthold, 1999). It has been
hypothesized that unassembled NR1 and NR2 subunits are being retained in the endoplasmic
reticulum until assembly, which then allows exit and expression on the cell surface (Wenthold et al.,
2003).
1.5.4 Developmental profile of NMDAR subunits and effect on kinetics
Whereas NR1 is continuously and ubiquitously expressed in the CNS, expression of the distinct NR2
subunits depends on the developmental stage and brain region (Monyer et al., 1994; Akazawa et al.,
1994). NR2B and NR2D subunits predominate in the neonatal brain, whereas NR2A and NR2C are
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expressed during postnatal development. The NR2A and NR2B subunits are the most widespread
NR2 subunits; the NR2C subunit is largely restricted to the cerebellum. In CA1 and CA3 pyramidal
neurons the NR2B subunit is expressed prenatally, whereas the NR2A subunit progressively
increases its expression (Monyer et al., 1994; Sheng et al., 1994) and synaptic incorporation during
postnatal development (Stocca and Vicini, 1998; Tovar and Westbrook, 1999) (Fig.3).
Fig. 3: Developmental NMDA subunit gene expression in the rat brain (X-ray film autoradiographs)
NR2A mRNA is widely expressed in the adult brain; NR2B mRNA is mainly forebrain specific: hippocampus and
neocortex. NR2A gene expression increases strongly during postnatal development in neocortex, hippocampus and
cerebellar granule cells. In contrast, during same postnatal periods, NR2B expression stay either constant, increases but
less so than that of NR2A, or decreases (e.g. in cerebellar granule cells) (Monyer et al., 1992).
The gradual replacement or supplementation of NR2B by NR2A increases the decay time of synaptic
NMDA-mediated currents (Cull-Candy et al., 2001). Although NR2A subunits are incorporated
synaptically late in development, NR2B subunits are still highly persistent at extrasynaptic sites
(Stocca and Vicini, 1998; Rumbaugh and Vicini, 1999; Tovar and Westbrook, 1999).
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Immunoblot analysis, using antibodies against distinct NMDA receptor subunits, indicates that the
NR2A and NR2B subunit proteins have developmental profiles in cultured cortical neurons similar
to those seen in vivo. NR1 and NR2B subunits display high levels of expression within the first
week. In contrast, the NR2A subunit is barely detectable at 7 days in vitro (DIV) and then gradually
increased to mature levels at DIV21 (Li et al., 1998) (Fig 4).
Fig. 4: Developmental expression pattern of NR2A and NR2B subunits in vitro
Protein expression for all NMDA receptor subunits increases with development. While the NR1 and NR2B subunits are
expressed as early as DIV1, the NR2A subunit is barely detectable at DIV7. Furthermore, while the expression of NR1
and NR2B subunits reach a plateau at DIV14, the expression of NR2A subunit increases further from DIV14 to DIV21
(Li et al., 1998).
When expressed recombinantly, the different NR2 subunits confer different properties to the
NMDAR channel, with the NR2A subunit increasing overall macroscopic current amplitude,
accelerating deactivation and increasing desensitization (defined as inactivation in the presence of
the agonist) and the NR2B subunit having the opposite effects (Monyer et al., 1992; Vicini et al.,
1998). However, some native NMDAR channels contain more then one type of the NR2 subunit in
the same assembly (Dunah et al., 1998; Sheng et al., 1994; Chazot and Stephenson, 1997b; Luo et
al., 1997). Although studies in a heterologous system suggest the formation of functional
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triheteromeric assemblies of NR1/NR2A/NR2B (Vicini et al., 1998; Tovar and Westbrook, 1999), it
is still unknown to what extent these assemblies form in vivo.
NR3B is expressed postnatally in ventral horn motor neurons where it might participate in
transmission in the spinal cord, a region in which glycine has long been known to have synaptic
actions (Chatterton et al., 2002).
1.5.5 The C-terminal tail of the NMDAR
The critical role of the C-terminal domain in receptor trafficking and stabilization at synaptic sites
has been shown not only for GABAB and AMPA receptors (Calver et al., 2001; Osten et al., 2000;
Pagano et al., 2001; Passafaro et al., 2001; Shi et al., 2001a), but also for NMDARs (Mori et al.,
1998; Sprengel et al., 1998; Steigerwald et al., 2000; Sheng and Pak, 2000). NR2A and NR2B both
contain very long C-terminal tails (627 and 644 amino acids), including a PDZ binding domain as a
site for protein-protein interactions (Kornau et al., 1997). The NR1 C-terminal tail is much shorter
(105 amino acids) and the predominant splice variant in the hippocampus (NR1-1a) has no PDZ
binding motif (Laurie and Seeburg, 1994; Nakanishi et al., 1992).
The C-termini of NR2 subunits of NMDA receptor interact with the PDZ domains of membrane-
associated guanylate kinases (MAGUKs), which include postsynaptic density-95 (PSD-95), PSD-93
and synapse-associated protein (SAP102) (Garner et al., 2000; Sheng, 2001; Tomita et al., 2001)
(Fig. 5). MAGUKs, which are linked to a number of other postsynaptic proteins, mediate interactions
with signal transduction molecules and may function to retain NMDA receptors at synapses
(Kennedy, 1998).
The C-terminus of the NR2 subunits has been also implicated in controlling the endocytosis rate
(Roche et al., 2001). Truncation of large regions of the NR2A C-terminus in gene-manipulated mice
causes a loss of synaptic enrichment of the NR2A subunit and the appearance of NMDA EPSCs with
smaller amplitudes and slower kinetics (Steigerwald et al., 2000), indicating that the C-terminus of
NR2 subunits might be critical for normal synaptic localization.
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Fig. 5: Multiple mechanisms for anchoring NMDA receptors
The NMDA receptor, here depicted as a heteromultimer of NR1 and NR2 subunits within the cell membrane, is anchored
to various structural elements via its C-terminal tails. NR1 interacts through its invariant C0 exon to the actin-binding
protein •-actinin, which is competitively inhibited by calmodulin (CaM) binding to the same C0 region. The alternatively
spliced C1 exon of NR1 binds both to the putative cytoskeletal-associated protein yotiao and to the neurofilament subunit
NF-L. NR2 subunits interact with PSD-95 and the NR2B subtype can also bind to •-actinin. PDZ domains of PSD-95 are
labeled 1, 2, and 3 (adapted from Sheng & Pak).
The C-terminal tails of NR2A and NR2B are potential targets for tyrosine kinases, CaM kinase II
(CaMK II) and protein kinases A and C (Moon et al., 1994; Wang and Salter, 1994; Köhr and
Seeburg, 1996; Omkumar et al., 1996; Leonard and Hell, 1997; Tingley et al., 1997).
Studies in mice lacking the NR2A C-terminal domain (NR2ADC/DC) suggest that C-terminal signaling
events are also critical for LTP induction (Kohr et al., 2003).
1.5.6 Mice expressing C-terminally truncated NR2 subunits
Mice that express NMDAR subunits lacking a large intracellular C-terminal receptor domain were
constructed by replacing in embryonic stem cells the C-teminal exons of the NR2A and NR2B
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subunit genes with the neomycin phosphotransferase (neo) gene preceded by in-frame translational
stop codons (Sprengel et al., 1998) (Fig. 6).
Fig. 6: NR2 subunits, full-length and truncated forms
The black boxes indicate the hydrophobic segments M1-M4 and the C-terminal aminoacids are listed below. The
overlying refer to the synthetically introduced residues (Sprengel et al., 1998).
Phenotypically these NR2•C/•C mice resemble those mice that are deficient in that particular subunit.
Thus, mice expressing the NR2B subunit in a C-terminally truncated form (NR2B•C/•C mice) die
perinatally, and NR2A•C/•C mice are viable but exhibit impaired synaptic plasticity and contextual
memory, indicating that the deletion of the C- terminal domain induced a functional knock-out of the
receptor. This functional NMDA receptor knock-out was not due to a lack of functional NMDA
receptor channels but appeared to reflect defective intracellular signalling of activated NMDA
receptors. The study with these mice clearly demonstrated that the intracellulary located C-termini of
the NR2 subunits are indispensable for the physiological functionality of the respective NMDA
receptor subtypes.
1.5.6 NMDAR subunits and synaptic plasticity
It has been hypothesized that the developmental switch from NR2B to NR2A at synaptic sites may
be responsible for the decreased plasticity observed in older animals (Carmignoto and Vicini, 1992;
Crair and Malenka, 1995). Interestingly, mice overexpressing NR2B show enhanced long-term
potentiation (LTP) and improved performance in behavioural tests for learning and memory (Tang et
al., 1999), which might be useful for developing strategies to combat cognitive disabilities. Mice
with a targeted disruption of the NR2A subunit have reduced LTP and deficiencies in certain
learning tests (Sakimura et al., 1995).
COOH
145-185 kDaCOOH
NH2
NH2
NR2
NR2DC
NR2ADC - LITFIWEHLFYWKLRFCFTGVCSDRPGDLSS*
NR2BDC - LITFICEHLFIWQFRHCFMGVCSGKP*
M1 M2 M3 M4
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1.5.7 NMDARs and disease
Ca2+ influx via NMDAR channels is believed to be essential in triggering synaptic plasticity, but
excessive Ca2+ influx can cause neuronal death. Consequently, blocking NMDARs is
neuroprotective in animal models of stroke and seizure (Lee et al., 1999), making NMDAR
antagonists a promising tool for treating these diseases. Interestingly, studies which used this strategy
found that some non-competitive antagonists elicited dopaminergic hyperactivity and schizophrenic
behavior (Rowley et al., 2001). In addition, mice with reduced NR1 expression (~5 % of normal
level, Mohn et al., 1999) or NR2A knock-out mice (Miyamoto et al., 2001) show symptoms
associated with schizophrenic behavior. NR2B antagonists were also suggested for pain treatment,
since overexpression of NR2B leads to increased sensitivity to inflammatory pain (Wei et al., 2001).
The NMDAR blocker amantadine is used in Parkinson therapy, although it is unclear whether its
therapeutic effect is caused by the NMDAR blockade (Blanpied et al., 1997).
Stroke is perhaps the condition with the stronger evidence for the role of excitotoxic mechanism,
therefore high expectations were directed towards therapy based on blocking excitatory amino acid
receptors. Unlike other organs, the brain can neither synthesize nor store energy reserves, and relies
exclusively on blood-borne glucose for its energy source. Any interruption in cerebral blood flow
will lead rapidly and irrevocably to energy depletion and a dramatic fall in the intracellular levels of
ATP. The immediately consequences is an increase in the concentrations of extracellular glutamic
acid followed by cerebral ischaemia. In a rat model of focal ischaemia, the extent of the rise in
extracellular glutamic acid has been shown to be correlated with the size of the lesions that
subsequently develop (Benveniste et al., 1984).
1.6 Excitotoxic cell death
1.6.1 Basic characteristics
Excitotoxicity is a term originally used by John Olney to refer to the ability of glutamate and
structurally related amino acids to destroy neurons (Olney, 1968). The basic nature of excitotoxicity
has been well established by in vivo studies beginning more then 20 years ago (Coyle et al., 1981;
McGeer and McGeer, 1982). High systemic doses of glutamate produce characteristic pathological
changes in the circumventricular regions of young rodent or monkey brains, for example, the arcuate
nucleus of the hypothalamus (Olney, 1969; Olney et al., 1972). Within 30 minutes of glutamate
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administration, electron microscopy reveals massive acute swelling of neuronal cell bodies and
dendrites, whereas axons and terminal buttons originating from cell bodies outside of the affected
region remain largely intact. These in vitro studies support the notion that injury may result from the
glutamate-induced overexcitation, and suggest also that a significant injury component may be
specifically triggered by excess of Ca2+ influx.
1.6.2 Mechanism of excitotoxicity
In vitro studies of excitotoxicity using cell culture models have implicated the NMDA receptor
subtype as being the principal vehicle of excitotoxic damage. In most cell culture models, it appears
that the excitotoxic effect of glutamic acid can be blocked by NMDA receptor antagonists (Choi et
al., 1988). In classical excitotoxicity experiments, elevated levels of extracellular glutamic acid cause
persistent depolarization of the neuron. This triggers a cascade of intracellular events that eventually
lead to cell death: sodium influx (A), calcium influx (B) and the glutamatergic loop (C). These three
elements are not independent and occur in parallel. Sodium entry is responsible for early necrotic
events, calcium entry for delayed neurodegenerative events, and exocytosis of glutamic acid for
spread and amplification of the degenerative process.
A. Depolarization is initiated primarily by activation of AMPA receptors and subsequently by
activation of voltage-dependent sodium channels. This leads to sodium entry and further
depolarization. The entry of sodium ions is followed by a passive entry of chloride ions in order to
maintain ionic equilibrium (Rothman, 1985). This is followed by entry of water, due to the osmotic
gradient, that causes an increase in cell volume (osmotic swelling) and a dilution of the cytoplasmic
contents, leading to disruption of organelles. The final consequence of osmotic swelling is cell lysis
and the release of the cell content into the extracellular milieu. This osmotic component of
excitotoxicity is potentially reversible if the depolarizing stimulus is removed (Choi, 1987).
B. Intracellular calcium levels are usually very low (~10-7 M) but when the cell is excessively
depolarized the Ca2+ levels rise persistently. The principal source of elevated intracellular free Ca2+,
in the presence of extracellular glutamic acid, is through the opening of NMDA receptor channels,
whose Mg2+ block will have been relieved upon depolarization. Using cell culture models, it has
been demonstrated that, at least in vitro, removal of extracellular calcium from the extracellular
milieu prevents the neurotoxicity of glutamic acid (Choi, 1985). However, the ability of neurons to
withstand excitotoxic damage may well be related to their ability to buffer intracellular calcium
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(Iacopino et al., 1992; Lukas and Jones, 1994). The rise in intracellular free Ca2+ concentration
stimulates the activity of numerous enzymes and triggers other Ca2+ dependent protein-protein
interactions that are ultimately deleterious to cell homeostasis, leading to neuronal death. Nucleases
disrupt the organization of chromatin in the nucleus and fragment DNA (Orrenius et al., 1989),
cytosolic proteases such as calpain attack the cytoskeleton (Siman et al., 1989; Mills and Kater,
1990), Ca2+ dependent cytosolic kinases modify the phosphorylation state on cytoplasmic proteins
and thus disrupt cell function (Favaron et al., 1990). A final consequence of the elevation of the
intracellular Ca2+ concentration is the activation of the exocytosis of neurotransmitter-containing
vesicles from nerve endings.
C. During the course of excitotoxicity, there is a strong increase in the extracellular concentrations of
glutamic acid. The principal cause is the release of intracellular cytosolic glutamic acid due to cell
lysis, slowing of glutamic acid transport subsequent to depolarization and the Ca2+-dependent
exocytosis of synaptic vesicles. The large concentrations of glutamic acid can then diffuse towards
other neurons and depolarize them in their turn. The extracellular glutamic acid thus plays a
facilitator role, further depolarizing already weakened neurons and spreading the depolarization to
healthy neurons in the vicinity. Such elevations of extracellular glutamate concentrations have been
well documented in cerebral ischaemia (Benveniste et al., 1984).
1.6.3 Clinical trials
Over the last 5 years, several clinical trials have been undertaken in stroke with NMDA receptor
antagonists. The results of these studies have been disappointing. Although results of pilot studies
did suggest some efficacy, larger controlled trials have failed to demonstrate a clear therapeutic
benefit. In most cases, the side effects of the drug used and, in some cases, increased mortality have
preempted continued clinical research. These side effects include CNS depression and
phychodysleptic effects. Three low-affinity NMDA receptor antagonists, sinnabidol (Belayev et al.,
1995), ARL 15896 (Cregan et al., 1997) and MS-153 (Umemura et al., 1996) remain in clinical
development for stroke and it remains to be seen whether any clinical benefit will overcome potential
safety concerns from associated side effects.
1.6.4 Role of the NR1 subunit in excitotoxicity
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Cultured neurons obtained from NR1 knock-out mice are resistant to NMDA- and glutamate-induced
excitotoxicity (Tokita et al., 1996). Similar results were obtained in cultures by suppressing NR1
expression with antisense oligonucleotides (Wahlestedt et al., 1993), a procedure that also reduces
focal ischaemic infarction in vivo (Wahlestedt et al., 1993). Investigations using mice expressing
NR1 mutations in the site critical for Ca2+ permeation (N598Q and N598R) showed that NMDA
receptor-mediated signaling was perturbed, and the mice failed to develop autonomic functions, such
as feeding and breathing (Single et al., 2000). All these observations can only suggest that functional
NMDA receptors are necessary for triggering receptor-dependent excitotoxicity, but cannot indicate
whether the NR1 subunit plays a distinct role in mediating neuronal death or survival.
1.6.5 Role of the NR2 subunits in excitotoxicity
It is well documented that immature cultured neurons are less vulnerable to glutamate neurotoxicity
(Choi et al., 1987; Barish et al., 1991; Marks et al., 1996; Wahl et al., 1989). This vulnerability
parallels the temporal expression pattern of different subunits, as the expression of NR2B and NR2D
begins at least as early as E14, whereas NR2A and NR2C are first detected postnatally (Monyer et
al., 1994; Sheng et al., 1994; Wenzel et al., 1997). Thus, a developmental switch in NR2 subtype
expression may underlie the increase in susceptibility to excitotoxicity over time. This
developmental switch in NR2 subtype expression is dependent on neuronal activity (Audinat et al.,
1994; Lindlbauer et al., 1998).  It was demonstrated  (Mizuta et al., 1998) that cortical neurons
exhibited increased glutamate sensitivity on day 11 in culture, whereas they were not affected by
glutamate on culture days 7-9. The authors concluded that glutamate neurotoxicity in these neurons
was mainly mediated by a heteromeric NR1-NR2B receptor, as they detected levels of NR2B and
NR1 on both days (8 and 11), whereas NR2A protein levels were hardly detectable at these ages in
vitro.
The development of mutant mice provides further insights into the role of distinct NR2 subunits in
neurotoxicity. Morikawa et al. (Morikawa et al., 1998) investigated the role of NR2A and NR2B
subunits in brain ischaemia using mutant mice deficient in NR2A (Sakimura et al., 1995; Kiyama et
al., 1998) and double mutants deficient in NR2A and NR2B. NR2A deficiency resulted in a
pronounced reduction in infarct volume. Infarct volume in mice lacking both NR2A and NR2B was
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not different than in NR2A deficiency alone. The authors suggested that NR2A subunits play an
important role in glutamate neurotoxicity.
Alternatives to knock-out mice are mutant mice expressing truncated NR2 subunits. Most express
gateable receptors that are synaptically activated, but are defective in intracellular signaling and
synaptic localization (Sprengel et al., 1998; Mori et al., 1998; Steigerwald et al., 2000). These data
suggest that the different NR2 subunits link NMDARs to downstream molecules that mediate
cellular responses to ions entering through the NMDAR channel.
1.7 The aim of this study
Since excitotoxicity has been implicated in a variety of neuropathological conditions, understanding
the pathways involved in this type of cell death is of critical importance to the future clinical
treatment of many diseases. The N-methyl-D-aspartate (NMDA) receptor has become a primary
focus of excitotoxic research because early studies demonstrated that antagonism of this receptor
subtype was neuroprotective.
Due to the high permeability to Ca2+, NMDA receptors are playing a critical role in neuronal cell
death. Extensive studies have documented that excitotoxicity is mediated by NMDA receptors due to
an excessive Ca2+-influx triggered by prolonged NMDA channel activation. However, the
contribution to excitotoxicity by the two major NR2 NMDA receptor subtypes, NR2A and NR2B,
has remained enigmatic.
This question is investigated in primary cortical cell cultures prepared from wild-type and gene-
manipulated mice expressing NR2A or NR2B subunits with altered signaling characteristics using
excitotoxicity experiments, Ca2+ influx analysis, subtype-specific pharmacological tools and
electrophysiological measurements.
Due to the lack of effective treatment in stroke therapy, research in the field of the NMDA receptor
antagonists has been extremely active in the last decade. This study indicates that both NR2A and
NR2B subunits are playing a critical role in excitotoxicity, and any NMDA receptor subtype specific
therapeutic intervention in stroke would lead to a failure.
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2. Materials and Methods
2.1 Cell culture
In order to prepare primary neuronal cell cultures from gene-manipulated mice, cortical cells from
each individual embryo were dissociated and plated separately. After culturing the cells, the body of
each embryo was used to genotype by PCR analysis the heterozygous, homozygous and wild-type
sister cultures.
2.1.1 Plates preparation
Glass coverslips placed into culture wells (24 wells plate, Greiner) were coated each with 300 ml
neuron-friendly substrate poly-D-lysine (5 mg/ml). The plates were kept in the 5 % CO2 incubator
for 24 hours. The poly-D-lysine substrate was washed two times with 1xPBS and the plates were
allowed to dry about two hours before plating the dissociated cortical neurons.
2.1.2 Dissection
The pregnant mouse was euthanized with halothane. Before making any incision, the abdomen was
wiped with 70 % ethanol. In order to minimize possible contamination from the fur or skin, the first
cut was done through the skin; the instruments were then rinsed with 70 % ethanol and the cut
through the abdominal wall was performed. The two horns of the uterus were gently removed and
placed in a sterile Petri dish containing cold PBS/ HEPES/ Glucose solution (4ºC). The remaining
steps were carried out in a laminar flow hood. The fetuses were removed from the uterus, decapitated
and the heads were transferred into a 50 ml Flacon tube containing cold PBS/ HEPES/ Glucose
solution (4ºC). The heads of the embryos were grasped firmly with a pair of Durmont-style forceps
by inserting the tips of the forceps deeply into the orbits. Using fine scissors, a midline incision
through the skin and skull was performed, beginning at the level of the decapitation and continuing
forward to the orbits. Then, with a second pair of forceps, this tissue was reflected away to each side
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so that the entire cortex was revealed. The brain was removed and transferred to a dissecting dish by
inserting the flat face of the forceps beneath the olfactory bulbs.
The hippocampi are C-shaped structures on the medial aspect of the cerebral hemispheres and were
removed in the next steps under a dissecting microscope at 10 to 15x magnification. The procedure
started by separating the cerebral hemispheres from the diencephalon and brainstem. With the basal
aspect of the brain facing up, the next cut was done along the boundary between the diencephalon
and the cerebral hemispheres. One blade of the forceps was placed into the space between the
hemisphere and diencephalon at the posterior pole, and then the cut was done forward and medially
around the diencephalon. The hemispheres were then separated so that the position of the
hippocampus on the medial aspect it could be seen. The brainstem and the diencephalon were
discarded.
In the next steps, the meninges and the choroid plexus were removed. The meninges form a thin
layer covering the surface of the brain and they can be easily recognized by the blood vessels, being
a highly vascularized structure. The choroid plexus lies within the ventricle, attaching to the
meninges at the fimbrial edge of the hippocampus. The hemispheres were stabilized with a pair of
forceps and with the help of another pair of forceps the meninges was grasped and tugged gently. By
beginning at one end of the hippocampus, it is usually possible to pull away the meninges overlying
the hippocampus as a single sheet. This procedure was done very gently, otherwise the traction on
the meninges could tear the underlying hippocampus and its removal became more difficult.
Once the meninges had been removed, the hippocampus was cut out. The two cerebral hemispheres
were lifted with the tip of the closed forceps and transferred into a 15 ml Falcon tube containing cold
PBS/ HEPES/ Glucose solution (4ºC).
2.1.3 Enzymatic digestion of the cortex
In the next step, the PBS/ HEPES/ Glucose solution was replaced with PBS cold solution (4ºC).
Using a 5 ml sterile pipette the cerebral hemispheres were transferred into a Petri dish and with a
sharp scalpel the tissue was chopped into very small pieces. Using the same pipette, the chopped
tissue was placed back into the 15 ml Falcon tube containing cold PBS solution (4ºC). This solution
was then fast replaced with 1.5 ml 2.5 % Trypsin and incubated at 37ºC for 7 minutes. During this
time the tube was shacken gently to prevent the setting of the tissue at the bottom of the tube and to
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allow a better contact between the tissue and the enzyme. After the incubation, the trypsin was
washed out two times with 5 ml warm PBS solution (37ºC) and then replaced with 1.5 ml
Neurobasal Media. Using a regular Pasteur pipette with a fire-polished tip (to avoid mechanical
tissue disruption) the tissue was dissociated by pipetting 10 to 12 times up and down. This step was
followed by a second dissociation, in which the fire-polished Pasteur pipette had a smaller diameter,
about half size than the original one. This step allowed a better dissociation of the tissue up to
individual cells.
2.1.4 Plating the cells
The density of the cells was determined using a hemacytometer. Only the viable cells were counted;
these cells were easily recognized using a drop of 0.8 % solution of Trypan blue to a small volume of
cell suspension. After 4 minutes the viable cells (the dye-excluding cells) were counted. Under
normal conditions, 85 % to 95 % of the cells should exclude Trypan blue. Plating of cells was done
rapidly to prevent the pH of the medium to become basic. The plating density used for all the
experiments was 3x105 cells/ ml.
2.1.5 Feeding and maintenance of neuronal cultures
Cultures were kept at 37ºC in a 5 % CO2 incubator. The cultures were fed 24 hours after plating the
cells and the medium was changed every four days. During feeding, the culture medium was never
changed completely; the neurons depend on the conditioning of the medium by glial cells for their
long-term survival. At each feeding only half of the medium was replaced. Cells were used for
experiments after 14 and 21 DIV.
2.1.6 Reagents and solutions
1xPBS without Calcium and Magnesium, sterile filtered (PAA Laboratories GmbH, H15-002)
PBS/ HEPES/ Glucose solution 7.38 pH:
100 ml 10xPBS (Gibco, 14200-067)
6 g D-(+)-Glucose (Sigma, G-7021)
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7.38 g Hepes (Roth, 9105-2)
adjust  pH to 7.38 with 2N NaOH
Neurobasal Medium without L-glutamine (Gibco, 21103-049)
B 27 Supplement 50x (Gibco, 17504-044)
L-glutamine 0.2M (Gibco, 25030-024)
Penicillin-Streptomycin (Gibco, 15140-114)
Culture medium:
500 ml Neurobasal Medium
10 ml B27 Supplement (50x)
1.25 ml L-glutamine (0.2M)
5 ml Penicillin-Streptomycin
0.25 % Trypsin in PBS w/o Calcium & Magnesium sterile filtered (PAA, L11-002)
Poly-D-Lysine Hydrobromide 1mg/ ml (Sigma, P-1149)
2.2 Neuronal toxicity experiments
Brief exposure to different concentrations of NMDA (0 to 100 mM NMDA) in the presence of 10
mM glycine was carried out at 37ºC in a 5 % CO2 incubator for 5-10 minutes, using an exposure
solution of serum-free media (Neurobasal Media without B27 Supplement). The exposure solution
was then replaced with culture medium and the plates were returned to the incubator for LDH
measurements the following day.
2.3 Assessment of neuronal injury
2.3.1 LDH assay
Overall neuronal injury was determined quantitatively by the measurement of lactate dehydrogenase
(LDH) in the bathing medium, an index proportional to the total number of damaged neurons (Koh
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and Choi, 1987). The LDH assay was performed 24 hours after NMDA exposure, at which point the
cell death process was largely complete.
Lactate dehydrogenase is a stable cytoplasmic enzyme present in all cells. It is rapidly released into
the cell culture supernatant upon damage of the plasma membrane. With the use of the Cytotoxicity
Detection Kit (Roche), LDH activity could be easily measured in culture supernatants by a single
measurement at one time point. The use of spectrophotometric microtiter plate reader (ELISA
reader) allowed the simultaneous measurement of multiple probes and thereby guaranteed the easy
processing of a large number of samples.
Background LDH levels were determined in sister cultures subjected to sham wash and subtracted
from experimental values to yield the signal specific to experimentally induced injury. LDH values
were scaled to the near-maximal mean value found in sister culture exposed to 100 mM NMDA for
24 hours (equal to 100 % cell loss).
Cytotoxicity (%) = [(Experimental Value – Low Control)/ (High Control – Low Control)] x 100
2.3.2 Trypan blue dye exclusion
Overall neuronal cell injury was estimated by examination of cultures with phase-contrast
microscopy at 100x magnification. The examination was performed 24 hours later after NMDA
exposure. In some experiments, this examination was verified by subsequent bright-field
examination of trypan blue staining.
Cells are able to exclude most large hydrophilic molecules from their cytoplasm until membrane
integrity has been severely compromised. In this assay, cell viability is assessed by the ability of the
healthy neurons to exclude trypan blue, a very hydrophilic dye. Cells were incubated in 0.4 % trypan
blue solution for 10 minutes. Nonviable cells were distinguished by their dark blue staining.
2.4 Mouse genotyping
The tips of mouse tails were digested by proteinase K (1 mg/ml) in TENS buffer (50 mM Tris-HCl
pH 8.0, 100 mM EDTA, 100 mM NaCl, 1 % SDS) at 55ºC. After precipitation in 1 volume of
isopropanol and washing with 70 % ethanol, genomic DNA was diluted in 300 mM sterile H2O
Materials and Methods
26
(millipore) at 55ºC. For PCR analysis 1 ml of this solution was used in an overall volume of 25 ml
containing PCR buffer (Gibco BRL), 2 mM MgCl2, dNTPs (0.2 mM per nucleotide), specific
oligonucleotides (0.4 mM each), 0.5 U Taq polymerase and ddH2O. An initial denaturating step (20
sec, 95ºC) was followed by 35 cycles each with 20 s at 94ºC (denaturing), 30 s at 55ºC (priming) and
50 s at 72ºC (elongation). After the last cycle, a final elongation was conducted for 10 min at 72ºC.
The size of PCR products was determined by agarose gel electrophoresis. The following
oligonucleotides were used for genotyping the respective mouse lines (expected bands in
parentheses):
NR1 -/-:        N1IN18up1, N1EX18do1 (wt: 1140 bp, -/-: 480 bp )
NR2ADC/DC: rspneo10, rspneo26 (wt: 700 bp, DC/DC: 1700 bp)
 rspneo6, rspneo26 (wt: 700 bp, DC/DC: 1100 bp)
NR2BDC/DC:  2B1, 2B3, rspneo6 (wt: 400 bp, DC/DC: 200 bp)
Sequences of oligonucleotides (5’-3’)
N1IN18up1    AGGGGAGGCAACACTGTGGAC
N1EX18do1   CTGGGACTCAGCTGTGCTGG
rspneo6           GCAATCCATCTTGTTCAATGGC
rspneo10         CCTGCTGATGGAGAAGAGCC
rspneo26         AGAAGCTAATGTACCTGAGG
2B1                 CGACATTGCTTCATGGGTGTCTGTTCTGGCA
2B3                 GGAACAAGCACCTTCTTGTCTC
The genotyping was performed after cortical cell preparation from each individual embryo.
2.5 Immunocytochemistry
Cultured neurons were fixed with 4 % paraformaldehyde, 4 % sucrose in PBS for 10 minutes at 4ºC
and permeabilized with 0.25 % Triton X-100 for 5 minutes. Cells were preincubated in 10 % goat
serum for 30 minutes at room temperature and then incubated in primary antibody in phosphate-
buffered saline (PBS) containing 5 % goat serum overnight at 4ºC. The concentrations of primary
antibodies were:
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rabbit N-terminal anti-NR2A subunit: 1 mg/ml (Belle)
mouse anti-MAP2: 1.5 mg/ml (Calbiochem)
mouse anti-NeuN: 1.5 mg/ml (Chemicon)
mouse anti-synapsin I: 1 mg/ml (Chemicon)
For double labelling, appropriate combinations of primary antibodies were incubated together. After
washing three times in PBS, cells were incubated with goat anti-rabbit and/or anti-mouse (Dianova
FITC-conjugated 1:50 or Dianova Cy3-conjugated 1:200) secondary antibodies for 1 hour at room
temperature. Coverslips were mounted on slides using Mowiol as mounting medium and visualized
using a microscope equipped for the visualization of fluorescence. Neurons were visualized through
10x, 40x and 100x objectives, and images were captured using a digital camera and transferred to a
computer workstation.
2.6 Colocalization analysis
Control and experimental groups of cells were always run in parallel within the same
immunohistochemical procedure. MethaMorph 6.1 software was used to interactively define the
NR2A and synapsin I clusters at two-fold cytoplasmic background for evaluation of cluster density
and size in single-channel analysis. Generating a dilated binary mask of synapsin clusters from the
same multichannel image determined cluster localization. All NR2A cluster regions with an average
binary pixel value that was greater than zero were defined as colocalized with synapsin I. Data
collected with MetaMorph were exported to a Microsoft Excel spreadsheet.
2.7 45Ca analysis
Cultures were washed with HEPES-buffered control salt solution (HCSS) that contains: 120mM
NaCl, 5mM KCl, 1.6mM MgCl2, 2.3mM CaCl2, 15mM glucose, 20mM HEPES, and 10mM NaOH.
In the next step, cells were incubated in the presence of different concentrations of NMDA (0 to 100
mM) in HCSS solution containing 45CaCl2. After 5 minutes, the exposure solution was quickly
washed out with three rinses of HCSS and the cells were lysed by addition of 0.2 % sodium dodecyl
sulfate (SDS) solution at 37ºC. Radioactivity was determined in the cell lysate. Calcium influx
through other channels was prevented by applying NMDA together with 10 mM 6-cyano-7-
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nitroquinoxaline-2-3-dione (CNQX, an AMPA/ kainate antagonist) and 2 mM nimodipine (a Ca2+
channel blocker).
2.8 Immunoblot analysis
Primary cultured neurons were scraped from the dish and collected by centrifugation (1000g for 10
minutes at 4ºC), followed by homogenization in ice cold buffer (pH 6.8, 50 mM Tris-HCl and 2 %
SDS). The amount of protein was determined by BCA protein assay. The indicated amount of
protein was loaded and separated using 7.5 % sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) under reducing conditions and transferred to nitrocellulose membranes.
The membranes were incubated in blocking buffer (5 % non-fat dry milk in Tris-buffered saline
containing 0.1 % Tween-20) for 1 hour at room temperature, and then incubated in blocking buffer
with subunit-specific antibodies directed against NR2A subunits and respectively Synapsin I
overnight at 4ºC. After washing for 30 minutes with four changes of Tris-buffered saline containing
Tween-20, the membranes were incubated with horseradish peroxidase-conjugated antimouse
antibody or antirabbit antibody (Amersham Life Science) for 1 hour at room temperature in blocking
buffer. Following several washes with Tris-buffered saline containing Tween-20, proteins were
visualized with enhanced chemiluminiscence (Pierce).
2.9 Electrophysiological recordings
Cultured cortical neurons at 14 and 21 DIV were visualized with a fixed-stage microscope (Axioskop
1, Zeiss, Jena, Germany), equipped with a 5´ objective (Plan-NEOFLUAR, Zeiss), a 60´ objective
(LUMPlanFl/IR, Olympus, Tokyo, Japan) and an infrared-sensitive video camera (C2400 07,
Hamamatsu, Japan). The preamplifier headstage holding the patch pipette was mounted on a
motorized micromanipulator (Mini 25, Luigs&Neumann, Ratingen, Germany). Patch pipettes were
pulled from borosilicate glass capillaries (Hilgenberg, Malsfeld, Germany) on a horizontal pipette
puller (P87, Sutter Instruments, Novato, CA, USA) and had resistances between 5 and 7 MW when
filled with intracellular solution. For fast application experiments a double-barreled pipette made of
borosilicate theta glass (Hilgenberg) was controlled by a piezo translator (P270, Physik Instrumente,
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Waldbronn, Germany) and perfused by a peristaltic pump (IPC-8, Ismatec, Glattbrugg, Switzerland).
The optical and mechanical components were mounted to a vibration-isolation table (Physik
Instrumente) and surrounded by a Faraday cage. Electrophysiological recordings were performed
with an EPC-9 amplifier (HEKA, Lambrecht, Germany) in voltage clamp mode. All recordings were
performed at room temperature on neurons with a characteristically pyramidal morphology.
2.9.1 Somatic recordings
Nucleated, whole-soma patches were obtained and 1 mM glutamate was fast-applied to activate
AMPAR- and NMDAR-mediated currents at a holding potential of –70 mV. Patch pipettes were
filled with (in mM): 140 CsCl, 2 MgATP, 10 EGTA, 10 HEPES (pH 7.25, 290-305 mOsM).
Extracellular solution contained (in mM): 135 NaCl, 5.4 KCl, 1.8 CaCl2, 5 HEPES (pH 7.25).
AMPAR-mediated currents were activated in the presence of the NMDAR antagonist D-AP5 (50
µM). NMDAR-mediated currents were activated in the presence of the NMDAR coagonist glycine
(10 µM) and the AMPAR antagonist NBQX (5 µM).
2.9.2 Synaptic recordings
Miniature excitatory postsynaptic currents (mEPSCs) were recorded at –70 mV in the same
extracellular solution as used for nucleated-patch recordings, additionally supplied with 10 µM
bicuculline methiodide (BMI, GABAA antagonist), 1 µM tetrodotoxin (TTX, sodium channel
blocker) and 10 µM glycine. Patch pipettes were filled with (in mM): 120 Cs-gluconate, 20 CsCl, 1
CaCl2, 4 MgATP, 0.3 NaGTP, 10 HEPES, 10 BAPTA, 2 TEA (pH 7.25, 290-305 mOsM).First,
composite AMPA and NMDA mEPSCs were recorded, then D-AP5 was washed in to record pure
AMPA mEPSCs. Events were analyzed off-line with the event detection program Peakscan (kindly
provided by Prof. Misgeld, Institute of Physiology, University of Heidelberg). Around 100 mEPSC
events were averaged for each condition. To obtain pure NMDAR-mediated currents, the averaged
trace of the pure AMPA component was digitally subtracted (Igor Pro WaveMetrics, Lake Oswego,
OR, USA) from the averaged trace of the composite AMPA and NMDA mEPSCs.
Data are presented as mean ± SEM. Statistical significance was evaluated by unpaired Student’s t-
test.
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3. Results
3.1 Introduction
NMDA-induced neurotoxicity in primary cultures of forebrain regions (neocortex and hippocampus)
is a commonly used model of neuronal injury; in these cultures, NMDA receptors clustered in
dendritic spines (O’Brien et al., 1998) mediate the most relevant pathophysiological processes, such
as those that initiate ischaemia (Sattler et al., 2000). However, it is still unclear how the two major
NMDAR subtypes expressed in the cultured cortical neurons NR1/NR2A and NR1/NR2B participate
in NMDA-mediated excitotoxicity.
To investigate the respective contribution of the NMDA receptor subtypes NR1/NR2A and
NR1/NR2B to excitatory cell death, NMDA-induced excitotoxicity experiments were performed in
cortical cell cultures. One strategy used to investigate this issue was to induce neuronal cell death in
gene-manipulated cultures prepared from mice expressing NR2A or NR2B subunits with altered
signaling properties.
NMDA receptors possess extended intracellular C-terminal domains by which they interact with
diverse proteins of the postsynaptic densities (PSD). This interaction plays a critical role in synaptic
localization, clustering and signal transduction (Sheng et al., 1996; Kennedy, 1997, 1998; Kornau et
al., 1997; Kim and Huganir, 1999).
In the cortical cultures prepared from NR2ADC/DC and NR2BDC/DC mice, neurons express NR2A and
NR2B subunits with impaired signaling, due to the C-teminal truncation. Primary cell culture is an
excellent system to study neurons from mice with lethal phenotype, such as NR1-/- or NR2BDC/DC
mice.
Another way of manipulation of the NMDA receptor subunits was a pharmacological approach in
wild-type cultures, using NR2A and NR2B subunit-specific antagonists in NMDA-induced
excitotoxicity protocol.
3.2 The cortical cell culture system and excitotoxicity
Since the NR2A and NR2B subunits show a distinct developmental expression profile in vitro (Li et
al., 1998), excitotoxicity experiments were performed at 14 and 21 DIV. At 14 DIV, the NR1 and
NR2B subunits are fully expressed whereas the NR2A subunit is expressed at a low level. At three
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weeks in culture, neurons become mature and express NR1, NR2A and NR2B subunits at their
highest level (Li et al., 1999).
In the first set of experiments, the preparation of cortical neurons was established and conditions
were optimized in order to keep the cultures up to three weeks in vitro.
Dissociated wild-type cortical neurons, plated at a density of 3x105 cells/ ml, were prepared from
E16 mouse embryos. Mature cultures consist of approximately 10 to 15 % neurons, as quantified by
immunocytochemistry analysis using antibodies against neuronal marker proteins such MAP2 and
NeuN (Fig. 7).
Fig. 7: High-density cortical cell culture.
Immunocitochemistry of primary cortical culture, 21 DIV. Neurons represent ~ 10 % of the entire cell population. MAP2
(green) stained the neurites, NeuN (red) labeled the neuronal cell body and DAPI (blue) marked the nuclei of all the cells
in culture. Neurons lie on the top of the astrocyte bed.
Dissociated cortical neurons from single embryos were plated in one 24 well plate, giving the
advantage to perform each excitotoxicity experiment in quadruplicate. Also, this protocol was
excellent to study NMDA-induced toxicity in cultures prepared from heterozygous mice, where the
preparation of the cells was done for each embryo, resulting in wild-type, heterozygous and
homozygous sister cultures.
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Increasing concentrations of NMDA applied for 10 minutes on cortical cells in culture produced a
dose-dependent increase of neuronal loss (Fig. 8). Application of 100 mM NMDA in wild-type
cultures led to 100 % neuronal loss at 14 DIV. 50 % cell death was induced by 50 mM NMDA (IC50).
At 21 DIV, mature cultures responded in a similar dose-response manner to NMDA exposure as
young cultures. The IC50 was consistent among sister cultures of a given plating.
Fig. 8: NMDA toxicity in wild-type culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed on sister cultures at two developmental stages, 14 and respectively 21 DIV. Values
represent STDEV of 6 independent experiments, each performed in quadruplicate. Statistical significance was evaluated
by unpaired Student’s t-test, p<0.05.
In additional exitotoxicity experiments, cultured neurons were exposed for 5 minutes to increasing
concentrations of NMDA. The cells were affected by the NMDA application in a similar dose-
response manner as after 10 minutes of NMDA bath application, indicating that a shorter exposure to
NMDA does not diminish the percentage of neuronal loss.
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After NMDA-induced excitotoxicity, the assessment of cell viability was performed using the LDH
assay and Trypan blue staining (Koh and Choi, 1987). Both methods gave the same percentage of
neuronal loss.
LDH is a colorimetric assay used for the quantification of cell death and cell lysis, based on the
measurement of lactate dehydrogenase activity released from the cytosol of damaged neurons into
the bath medium (Koh and Choi, 1987). A potentially important advantage of the LDH assay over
many other assays for cytotoxicity is that it is completely non-invasive. The biological environment
of the cultures is not altered and performance of the assay does not preclude subsequent or serial
measurements.
The trypan blue assay was mostly used for a morphological analysis of the cultures after the NMDA-
induced excitotoxicity. In this assay, neuronal loss is quantified based on the ability of healthy cells
to exclude trypan blue, a very hydrophilic dye. However, LDH analysis was preferred, being a very
reliable and fast method to investigate the percentage of cell death induced by NMDA application.
3.3 Excitotoxicity in NR1-/- cortical cultures
Once NMDA-induced toxicity was established in wild-type cultures, a positive control experiment
was performed: embryos with gene ablation of the NR1 subunit (NR1-/-) were used to prepare
cortical cultures. (Forrest et al., 1994).
NR1 is the obligatory subunit for the functional NMDA receptor channel, thus mouse mutants
without the NR1 subunit have no functional NMDARs, leading to perinatal death in the absence of
obvious morphological brain abnormalities (Forrest et al., 1994; Li et al., 1994), thereby indicating
important functions for NMDARs in brain physiology.
To prepare neuronal cultures from NR1-/- mice, heterozygous parents (NR1+/-) were bred and cortex
from single embryos was used for cell preparation. After plating the cells, individual embryos were
genotyped by PCR analysis to distinguish between wild-type, heterozygous and homozygous sister
cultures.
NMDA application showed no toxic effect in cultures prepared from the NR1-/- mice compared to the
wild-type sister cultures (Fig. 9). These observations suggest that functional NMDA receptors are
necessary for triggering receptor-dependent excitotoxicity, but actually cannot indicate whether the
NR1 subunit plays a more distinct role in mediating neuronal death or survival.
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Fig. 9: No NMDA toxicity in NR1-/- culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed at 21 DIV on NR1-/- and wild-type sister cultures. Results were normalized to the 100 %
cell death produced by 300 mM NMDA exposure on wild-type sister cultures. Values represent STDEV of 2 independent
experiments, each performed in quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
3.4 NMDA-induced toxicity in gene-manipulated cultures
Direct interactions occur between NMDA receptor subunits and members of the postsynaptic density
(PSD) protein family. In mice expressing NR2 subunits in a C-terminal truncated form, the
interactions with constituents of the PSD are occluded and the intracellular signaling of these
subunits is impaired.
NMDA-induced toxicity in gene-manipulated cultures is a very useful tool to investigate the
contribution of the NR2A and NR2B subunits to excitatory cell death.
The gene-manipulated mice used in this study express C-terminally truncated NR2A (NR2ADC/DC
mice) and NR2B (NR2BDC/DC mice) subunits.
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3.4.1 NMDA-induced toxicity in NR2ADC/DC cultures
In the first set of experiments, NMDA toxicity was induced in cultures prepared from NR2ADC/DC
mice. In these mice, the C-terminal tail of the NR2A subunit is truncated. The intracellular NR2A
receptor domain that may mediate interaction of the ion channel with components transducing the
synaptically evoked Ca2+ signal is functionally impaired.
In cultures prepared from NR2ADC/DC embryos, the neurons expressed all the NR2A subunits in C-
terminally truncated form with altered signal properties.
NMDA application in young (14 DIV) NR2ADC/DC cultures triggered neuronal cell death in a similar
dose-response manner as in wild-type sister cultures (Fig. 10).
Fig. 10: NMDA toxicity in NR2ADC/DC culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed at 14 DIV on NR2ADC/DC and wild-type sister cultures. The NMDA toxicity is similar in
wild-type and NR2ADC/DC cultures. Values represent STDEV of 5 independent experiments, each performed in
quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
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This result can be explained by the low expression level of the NR2A subunit at 14 DIV.
Interestingly, in mature NR2ADC/DC cultures (21 DIV), NMDA had a similar toxic effect as that
observed in wild-type cultures (Fig. 11).
Fig. 11: NMDA toxicity in NR2ADC/DC culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed at 21 DIV on NR2ADC/DC and wild-type sister cultures. The NMDA toxicity is similar in
wild-type and NR2ADC/DC cultures. Values represent STDEV of 5 independent experiments, each performed in
quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
NR2ADC/DC cultures showed NMDA-induced excitotoxicity similar to wild-type cultures. Short
application of increasing NMDA concentration (10 minutes) triggered visible neuronal cell death
(Fig. 12).
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Fig. 12: NMDA-induced toxicity in NR2ADC/DC culture
Phase-contrast micrographs of identified fields of cortical cells taken one day after a 10 minutes exposure to 100mM
NMDA (bright field after trypan blue incubation) on wild-type (A, C) and NR2ADC/DC cultures (B, D). NMDA
application had a similar toxic effect on wild-type and NR2ADC/DC cultures. Scale bar 50mm.
So the impairment in the interaction of the NR2A subunits with the PSD proteins did not change the
sensitivity to NMDA-induced cell death. One explanation is that in NR2ADC/DC cultures
excitotoxicity is mediated mainly via the NR2B subunit.
To investigate if the truncated NR2A subunits are located at synaptic sites, an immunocytochemistry
approach was used.
At synaptic sites in the NR2ADC/DC cultures, the intensity of NR2A-containing synapses was reduced
when compared with NR2A in wild-type cultures. In mature NR2ADC/DC cultures a strong reduction
was observed in the NR2A receptor localization at synaptic sites (Fig.13).
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Fig. 13: Immunofluorescent staining of NR2A subunits and Synapsin in wild-type and NR2ADC/DC cultures
Double labeling for NR2A subunits (anti-mouse C-terminus antibody, 1mg/ml) and Synapsin I (anti-rabbit, 1 mg/ml) in
cortical cells at 21 DIV. Scale bar 10 mm.
Colocalization analysis indicated a reduction of the NR2A subunit in the synapse of about 1/3 in the
NR2ADC/DC cultures compared to the wild-type (Fig 14).
Fig. 14: Colocalization of NR2A subunits with Synapsin in wild-type and NR2ADC/DC culture
Colocalization analysis of NR2A subunits and Synapsin I (MetaMorph InVisitron System). Strong reduction of NR2A-
containing synapses in NR2ADC/DC cultures compared to wild-type. Values represent STDEV of quantified
colocalizations in 4 to 5 cells from 3 independent experiments. Statistical significance was evaluated by unpaired
Student’s t-test, p<0.05.
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To investigate the contribution of the NR2B receptor subtype to excitotoxicity in NR2ADC/DC
cultures, an NR2B subunit-specific antagonist ifenprodil was used during NMDA exposure. In the
presence of ifenprodil, young cultures were protected from the NMDA-induced cell death (Fig.15).
These data confirm that in young NR2ADC/DC cultures, excitotoxicity is mediated via the NR1/NR2B
receptors, the most abundant NMDA receptor subtype at 14 DIV.
Fig. 15: NMDA-induced toxicity in young NR2ADC/DC culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of ifenprodil (10 mM). Experiments were performed at 14 DIV on NR2ADC/DC cultures. NMDA toxicity is
mediated by the NR2B subunit. Values represent STDEV of 5 to 6 independent experiments, each performed in
quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
Interestingly, mature cultures (21DIV) were also protected from NMDA-toxicity in the presence of
NR2B antagonist (Fig. 16).
0
10
20
30
40
50
60
70
80
90
100
%
 n
eu
ro
na
l l
os
s
0 50 100 mM NMDA
NMDA toxicity
NMDA + ifenprodilNMDA
*
*
Results
40
Fig. 16: NMDA-induced toxicity in mature NR2ADC/DC cultures
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of ifenprodil (10 mM). Experiments were performed at 21 DIV on NR2ADC/DC cultures. NMDA toxicity is
mediated by the NR2B subunit. Values represent STDEV of 5 to 6 independent experiments, each performed in
quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
So at a mature stage, when NR2A subunit function is abolished, the NR2B subtype is the only
mediator of the NMDA-induced toxicity.
This may reflect the inability of truncated NR2A channels to access or trigger the “death program”
and probably due to a compensatory mechanism, NR2B subunits are the only mediators in the
excitatory cell death. 
Western blot analysis (performed by Jakob von Engelhardt) indicated that in the NR2ADC/DC cultures,
the NR2B subunit is expressed at levels comparable to wild-type. The alteration of the intracellular
signaling of the NR2A subunits did not affect the expression level of the NR2B subtype (Fig 17).
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Fig. 17: Western blot analysis of NR2B subunit protein in wild-type and NR2ADC/DC cultures
Cells at 21 DIV were harvested and membrane homogenates were separated by SDS-PAGE. After transferring to
nitrocellulose membrane, the expression profile of NR2A subunits and Synapsin I (presynaptic marker used as positive
control) was determined using specific antibodies against NR2A and Synapsin I poplypeptides. NR2B subunit is
expressed in NR2ADC/DC cultures at levels comparable to wild-type cultures. Experiments were performed in duplicate by
Jakob von Engelhardt.
There is a strong relationship between NMDA-triggered excitotoxicity and excessive Ca2+ influx
through NMDA receptors. There is undoubtedly a large diversity of pathways for Ca2+ entry into
neurons, but the NMDA pathway plays the key role in neuronal death.
It is still controversial whether excitotoxicity itself is a truly significant player in the stroke process
or the additional mechanisms of excitotoxicity are more important. Ca2+-dependent neurotoxicity, as
with many physiological events, occurs through distinct intracellular signaling pathways, likely
through physical interactions of cell membrane receptors with specialized submembrane molecules.
Because the key mediators of excitotoxic damage are Ca2+, an important issue was to investigate the
45Ca influx through NMDA receptors in the NR2ADC/DC cultures.
At 21 DIV, application of NMDA in NR2ADC/DC cultures triggered a similar influx of Ca2+ as in
wild-type cultures (Fig.18). Jokob von Engelhardt performed NMDA-evoked 45Ca influx
experiments.
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Fig. 18: 45Ca influx in NR2ADC/DC culture
At 21 DIV in NR2ADC/DC cultures the 45Ca influx is similar with wild-type. For measurement of Ca2+ influx, 45Ca was
added during the NMDA exposure for 5 minutes; cultures were then washed thoroughly and 45Ca activity was measured.
Values represent mean ± SEM of 6 to 9 independent experiments performed by Jakob von Engelhardt. Statistical
significance was evaluated by unpaired Student’s t-test, p<0.05.
Moreover, NMDA-induced Ca2+ influx was suppressed by ifenprodil application, indicating that in
these cultures Ca2+ enters only through NR1/NR2B channels (Fig.19).
In summary, excitotoxicity experiments, immnunocytochemistry, Western blot analysis and Ca2+
influx indicated that in cultured cortical neurons expressing NR2A subtype only in its C-terminally
truncated form, NMDA-mediated killing occurs efficiently via the NR2B channels, both at 14 DIV
and 21 DIV.
Electrophysiological experiments were further performed by Verena Pawlak (MPI for Medical
Research, Heidelberg) to investigate if there is any change in the synaptic and extrasynaptic currents
in the NR2ADC/DC cultures.
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Fig. 19: 45Ca influx occurs through NR2B channels in NR2ADC/DC culture
At 21 DIV in NR2ADC/DC cultures the Ca2+ influx occur mainly via the NR2B subunit. For measurement of Ca2+ influx,
45Ca was added during the NMDA exposure for 5 minutes; cultures were then washed thoroughly and 45Ca activity was
measured. Values represent mean ± SEM of 6 to 9 independent experiments performed by Jakob von Engelhardt.
Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
Nucleated patches indicated no difference in the extrasynaptic currents in mature NR2ADC/DC cultures
compared with wild-type sister cultures (Table 1A). Furthermore, the synaptic currents indicated by
mEPSC recordings were also unchanged (Table 1B).
A Somatic currents (-70 mV)
wild-type                                           NR2A DC/DC
NMDA Amplitude (pA/pF) -108 ± 18                                                 -96 ± 31
Deactivation (ms) 65 ± 13                                                  42 ± 6
AMPA Amplitude -296 ± 51                                              -553 ± 150
NMDA / AMPA  0.44 ± 0.08                                           0.30 ± 0.08
NMDA + ifenprodilNMDA
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B Synaptic currents (-70 mV)
wild-type                                           NR2A DC/DC
NMDA Amplitude (pA) -6.9 ± 1.3                                                 -4.3 ± 0.7
NMDA Charge (pC) -0.28 ± 0.05                                             -0.18 ± 0.04
AMPA Amplitude (pA) -36 ± 2                                                     -25 ± 2
Rise time (ms) 0.5 ± 0.0                                                   0.6 ± 0.0
Deactivation (ms) 2.9 ± 0.2                                                   3.1 ± 0.3
Charge (pC) -0.15 ± 0.01                                             -0.15 ± 0.02
NMDA / AMPA 0.18 ± 0.03                                              0.17 ± 0.02
Table 1: Synaptic and extrasynaptic currents in NR2ADC/DC culture
The table summarizes data obtained from three-week-old (DIV21) primary cortical cultures prepared from wild-type and
NR2ADC/DC mice: NMDA or AMPA peak currents, charges and kinetics. Extrasynaptic AMPA/NMDA ratios were
unchanged in NR2ADC/DC cultures compared to wild-type sister cultures, as indicated by the nucleated patches (A).
mEPSCs recordings indicate comparable AMPA/NMDA amplitude ratios between wild-type and NR2ADC/DC cultures
(B). Experiments were performed by Verena Pawlak, MPI for Medical Research, Heidelberg.
All the investigations in the NR2ADC/DC cultures suggested that in the absence of fully functional
NR2A subunits, due to a compensatory mechanism, the NR1/NR2B receptor subtype became the
only Ca2+ influx mediator and also the only NMDA receptor subtype responsible for excitatory cell
death.
3.4.2 NMDA-induced toxicity in the NR2B DC/DC cultures
The NMDA-induced toxicity analysis in cultures that express the C-terminally truncated NR2B
subunit is particularly interesting, because the NR1/NR2B receptors are most likely the first
ionotropic glutamate receptors expressed at nascent, functionally immature synapses (Durand et al.,
1996; Malenka and Nicoll, 1997).
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NMDA toxicity was induced in cultures prepared from NR2B DC/DC embryos. In these cultures, the
neurons express the NR2B subunit in the C-terminally truncated form with impaired signal
properties.
Interestingly, the application of different concentrations of NMDA had no toxic effect in the young
NR2BDC/DC cultures (Fig. 20) compared with wild-type sister cultures.
Fig. 20: NMDA-induced toxicity in young NR2BDC/DC culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed at 14 DIV on NR2BDC/DC cultures. NMDA application had no toxic effect. Values represent
STDEV of 5 to 6 independent experiments, each performed in quadruplicate. Statistical significance was evaluated by
unpaired Student’s t-test, p<0.05.
Furthermore, mature NR2BDC/DC neurons in culture were also protected from the toxic effect of
NMDA (Fig. 21).
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Fig. 21: NMDA-induced toxicity in mature NR2BDC/DC culture
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA.
Experiments were performed at 21DIV on NR2BDC/DC cultures. NMDA application had no toxic effect. Values represent
STDEV of 5 to 6 independent experiments, each performed in quadruplicate. Statistical significance was evaluated by
unpaired Student’s t-test, p<0.05.
NR2BDC/DC cultures showed a strong protection to NMDA-induced excitotoxicity. Short application
(10 minutes) of a high NMDA concentration (1mM) did not trigger any visible neuronal cell death.
Almost all neurons could be found intact one day after exposure. These surviving cells excluded
trypan blue and remained morphologically stable for at least several more days (Fig 22).  These
experiments show that the NR2BDC/DC cultures are as resistant as NR1-/- cultures to NMDA-induced
excitotoxicity.
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Fig. 22: NMDA-induced toxicity in NR2BDC/DC culture
Phase-contrast micrographs of identified fields of cortical cells taken one day after a 10 minutes exposure to 100mM
NMDA (bright field after trypan blue incubation) on wild-type (A, C) and NR2BDC/DC cultures (B, D). NMDA application
had no toxic effect on NR2BDC/DC cultures. Scale bar 50 mm.
NMDA receptor activation leads rapidly to Ca2+ influx and the accumulation of high levels of
intracellular Ca2+ triggers the cell death cascade. Could the C-terminal truncation of the NR2B
subunit impair the Ca2+ influx through NMDAR channels in the NR2BDC/DC cultures?
45Ca analysis indicated no Ca2+ influx through NMDA receptors in the NR2BDC/DC mature cultures,
compared with wild-type sister cultures (Fig.23). These results suggested that the NR2A subunit
could not substitute or provide any compensation for the impaired functionality of the NR2B subunit.
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Fig. 23: 45Ca influx through NMDA receptor channels in NR2BDC/DC culture
At 21 DIV in NR2BDC/DC cultures there is no NMDA-induced calcium influx. For measurement of Ca2+ influx, 45Ca was
added during the NMDA exposure for 5 minutes; cultures were then washed thoroughly and 45Ca activity was measured.
Values represent mean ± SEM of 5 to 6 independent experiments performed by Jakob von Engelhardt. Statistical
significance was evaluated by unpaired Student’s t-test, p<0.05.
Since NMDA applications did not trigger any cell death and 45Ca analysis shows no Ca2+ influx in
NR2BDC/DC cultures, an important issue was to investigate the NR2A subunit expression and
localization in these cultures, using Western blot analysis and elecrophysiological recordings.
Western blot analysis in homogenates obtained from mature NR2BDC/DC cultures (21 DIV) indicated
that the NR2A subunit was expressed at levels comparable with those observed in wild-type cultures
(Fig.24). This experiment suggested that the functional impairment of NR2B subunit did not affect
the level of the NR2A subunit expression. The NR2A NMDA receptor subtype was also normally
transported to the cell membrane surface, as indicated by the Western blot analysis.
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Fig. 24: Western blot analysis of NR2A subunit protein in wild-type and NR2BDC/DC cultures
Cells at 21 DIV were harvested and membrane homogenates were separated by SDS-PAGE. After transferring to
nitrocellulose membrane, the expression profile of NR2A subunits and Synapsin I (presynaptic marker used as positive
control) was determined using specific antibodies against NR2A and Synapsin I poplypeptides. NR2A subunit is
expressed in NR2BDC/DC cultures at levels comparable to wild-type cultures. Experiments were performed in duplicate by
Jakob von Engelhardt.
Interestingly, electrophysiological measurements showed a reduction in the synaptic and somatic
NMDA currents. Nucleated patches in NR2BDC/DC cultures indicated that somatic currents were
reduced by one-third compared with those seen in wild-type sister cultures (Table 2A). Synaptic
currents, indicated by mEPSC recordings, were however reduced by two-thirds in NR2BDC/DC
cultures compared with wild-type (Table 2B).
A Somatic currents (-70 mV)
wild-type                                           NR2A DC/DC
NMDA Amplitude (pA/pF) -108 ± 18                                                 -73 ± 21
Deactivation (ms) 65 ± 13                                                  34 ± 5
AMPA Amplitude -296 ± 51                                              -580 ± 178
NMDA / AMPA  0.44 ± 0.08                                           0.18 ± 0.05
wild type NR2B D C/ D C
¬ NR2A
¬ Synapsin I
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B Synaptic currents (-70 mV)
wild-type                                           NR2A DC/DC
NMDA Amplitude (pA) -6.9 ± 1.3                                                 -1.3 ± 0.5
NMDA Charge (pC) -0.28 ± 0.05                                             -0.04 ± 0.01
AMPA Amplitude (pA) -36 ± 2                                                     -25 ± 4
Rise time (ms) 0.5 ± 0.0                                                   0.6 ± 0.0
Deactivation (ms) 2.9 ± 0.2                                                   3.8 ± 0.5
Charge (pC) -0.15 ± 0.01                                             -0.14 ± 0.04
NMDA / AMPA 0.18 ± 0.03                                              0.06 ± 0.03
Table 2: Synaptic and extrasynaptic currents in NR2BDC/DC culture
The table summarizes data obtained from three-week-old (DIV21) primary cortical cultures prepared from wild-type and
NR2BDC/DC mice: NMDA or AMPA peak currents, charges and kinetics. Extrasynaptic AMPA/NMDA ratios were
reduced by half in NR2BDC/DC cultures compared to wild-type sister cultures, as indicated by the nucleated patches  (A).
mEPSCs recordings indicate reduced by one third AMPA/NMDA amplitude ratios NR2BDC/DC cultures compared to
wild-type (B). Experiments were performed by Verena Pawlak, MPI for Medical Research, Heidelberg.
Western blot analysis and elecrophysiological recordings clearly indicate that in NR2BDC/DC cultures,
in which the NR2B subunit has impaired signaling properties, the NR2A subtype is expressed at
normal levels; it is transported to the cell membrane but does not reach the synaptic sites, remaining
extrasynaptically located. These findings suggest that normal NR2B signaling is required for the
postsynaptic presence of NR2A-containing channels.
3.5 NMDA-induced toxicity in wild-type cultures
To investigate the contribution of NR2A and NR2B subtypes to excitatory cell death, NMDA
toxicity experiments were performed in wild-type cultures. A pharmacological approach using the
NR2B and NR2A subunit-specific antagonists offered the advantage to study these receptor subtypes
in wild-type high-density cultures. In this system both NR2A and NR2B subunits are normally
expressed with unaltered functional properties. By blocking any of these two NMDA receptor
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subtypes, excitotoxicity experiments indicated the contribution to neuronal cell death of the
remaining “available” NR1/NR2 subunit combination.
3.5.1 NMDA-induced toxicity in the presence of the NR2B subunit-specific antagonist
Application of NMDA in the presence of the NR2B subunit-specific blocker (ifenprodil) had a
protective effect in young wild-type cultures (Fig. 25). This neuronal protection indicated that at 14
DIV, when the NR2A subunit is expressed at low levels, the NR2B subtype is the only mediator of
the NMDA-induced excitotoxicity.
Fig. 25: NMDA-induced toxicity in young wild-type culture in the presence of ifenprodil
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of ifenprodil (10 mM). Experiments were performed at 14 DIV on wild-type cultures. In the presence of
ifenprodil, NMDA toxicity is mediated by the NR2B subunit. Values represent STDEV of 5 to 6 independent
experiments, each performed in quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
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At 21 DIV, when the NR2A subunit reaches the highest expression levels, cultures exposed to
NMDA in the presence of ifenprodil were not protected anymore from the toxic effect. This result
indicates that in mature cultures, by blocking the NR2B subunit, toxicity becomes mediated mainly
via the NR2A-containing channels (Fig. 26).
Fig. 26: NMDA-induced toxicity in mature wild-type culture in the presence of ifenprodil
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of ifenprodil (10 mM). Experiments were performed at 21 DIV on wild-type cultures. In the presence of
ifenprodil, NMDA toxicity is mediated via the NR2A subunits. Values represent STDEV of 5 to 6 independent
experiments, each performed in quadruplicate. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
In summary, NMDA application triggers neuronal cell death mainly due to the NR2B subunits in
young wild-type cultures. At a later stage in vitro, when the NR2B subunit is blocked by ifenprodil,
excitotoxicity is mainly mediated via the NR2A subtype.
0
10
20
30
40
50
60
70
80
90
100
%
 n
eu
ro
na
l l
os
s
NMDA toxicity
0 50 100 mM NMDA
NMDA + ifenprodilNMDA
Results
53
3.5.2 NMDA-induced toxicity in the presence of the NR2A subunit-specific antagonist
A big advantage to study the NR1/NR2A subunit contribution to toxicity was to use a newly
developed drug, NVP-AAM077, which is an NR2A subunit-specific antagonist (Novartis Pharma
AG, Switzerland).
In young cultures NMDA application in the presence of NR2A blocker triggered neuronal loss in a
normal dose-response manner, since at this age in vitro the NR2A subunit is expressed at low levels
(Fig 27).
Fig. 27: NMDA-induced toxicity in young wild-type culture in the presence of NVP-AAMO77
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of NVP-AAM077 (0.05 mM). Experiments were performed at 14 DIV on wild-type cultures. The presence of
NR2A subunit antagonist had no protective effect to NMDA-induced toxicity at 14DIV. Values represent STDEV of 5 to
6 independent experiments, each performed in quadruplicate. Statistical significance was evaluated by unpaired Student’s
t-test, p<0.05.
In contrast, at 21 DIV, application of NMDA in the presence of NR2A subunit-specific antagonist
led to a strong neuronal cell death (Fig 28). Interestingly, 50 mM NMDA led to almost 100 % cell
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death, suggesting that the NR2A blocker application during NMDA exposure triggers probably a
more “aggressive” cell death pathway.
Fig. 28: NMDA-induced toxicity in mature wild-type culture in the presence of NVP-AAMO77
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of NVP-AAM077 (0.05 mM). Experiments were performed at 21 DIV on wild-type cultures. The presence of
NR2A subunit antagonist had no protective effect to NMDA-induced toxicity. Values represent STDEV of 5 to 6
independent experiments, each performed in quadruplicate. Statistical significance was evaluated by unpaired Student’s
t-test, p<0.05.
Notably, the application of the NR2A subunit-specific blocker, NVP-AAM077, has no cytotoxic
effect. A series of experiments were performed using different concentrations of NR2A blocker: 0.5
mM, 0.1 mM and 0.05 mM. In all the experiments the results were similar.
In summary, in mature cultured neurons, neither the NR2A antagonist NVP-AAM077 nor the NR2B
antagonist ifenprodil protected the cells from NMDA-mediated toxicity, indicating that both NR2A
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and NR2B subtypes are responsible for excitotoxicity. Notably, the cells were protected when both
NR2A and NR2B subunits were blocked during NMDA application (Fig. 29).
Fig. 29: NMDA-induced toxicity in wild-type culture in the presence of NVP-AAMO77 and ifenprodil
Neuronal viability of cortical neurons in vitro 24 hours after 10 minutes exposure to either 50 or 100 mM NMDA in the
presence of NVP-AAM077 (0.05 mM) and ifenprodil (10mM). Experiments were performed 21 DIV on wild-type
cultures. The presence of NR2A and NR2B subunit antagonists protected cells from NMDA-induced toxicity. Values
represent STDEV of 4 to 5 independent experiments, each performed in quadruplicate. Statistical significance was
evaluated by unpaired Student’s t-test, p<0.05.
Control experiments were performed with the NR2A subunit specific antagonist on NR2ADC/DC
cultures. Application of NMDA in the presence of NVP-AAM077 induced a toxic response as did
NMDA application alone, indicating that the NR2A antagonist has not side effects and is not toxic
itself when applied to neurons in culture. Furthermore, at 21 DIV, 45Ca analysis indicated that in the
presence of the NR2B subunit-specific blocker, Ca2+ influx became reduced by half, suggesting that
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in mature cultures NR2A and NR2B are roughly equally contributing to NMDA-induced Ca2+ influx
(Fig. 30).
Fig. 30: 45Ca influx through NMDA receptor channels in wild-type cultures in the presence of ifenprodil
At 21 DIV in wild-type cultures the NR2A and NR2B subunis equally mediated NMDA-induced Ca2+ influx. For
measurement of Ca2+ influx, 45Ca was added during the NMDA exposure for 5 minutes; cultures were then washed
thoroughly and 45Ca activity was measured. Values represent mean ± SEM of 5 to 6 independent experiments performed
by Jakob von Engelhardt. Statistical significance was evaluated by unpaired Student’s t-test, p<0.05.
These results indicate that the differences in the developmental expression pattern of NR2A and
NR2B might play a critical role in NMDA-evoked toxicity. In young cultures, the NR2B subtype is
responsible for excitotoxicity. In mature cultures, both NR2A and NR2B are roughly equally
contributing to NMDA-induced Ca2+ influx and excitotoxicity. Only the combined action of the
NR2A and NR2B subunit-specific antagonists could protect the cells from NMDA-induced
excitotoxicity.
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4. Discussion
Neurological diseases affect the humans in memory, cognition, language, personality and skilled
movements. Cerebrovascular diseases (stroke syndromes) are a major cause of morbidity and
mortality in middle and later life.
Inappropriate activation of NMDARs has been implicated in the etiology of several disease states. In
particular, excessive Ca2+ influx through NMDARs can cause excitotoxic neuronal death, and thus
blockade of NMDARs is neuroprotective in animal models of both stroke and seizure (Li et al.,
1999). Stroke was, therefore, the first clinical indication considered for NMDARs antagonists, but
the usefulness of most drugs was limited by their actions on normal synaptic transmission or by
additional side effects. Many of NMDAR antagonists lacking psychotic side-effects that have been
considered for the treatment of stroke failed to live up to preclinical expectations, showing little or
no therapeutic benefit.
4.1 NMDA receptor subtypes in excitotoxicity
In recent years, the study of excitotoxicity has been carried out in a variety of simplified in vitro
preparations, including cell culture, tissue culture, retina and brain slice. Information gathered in
such simplified systems has generally been consistent with in vivo observations, and has produced
additional information about underlying mechanisms. However, it is clear that important differences
can occur by studying the nature of excitotoxicity using different neuronal preparations.
NR1/NR2A and NR1/NR2B are the two major NMDA receptor subtypes expressed in principal
neurons. These receptors play an important role in synaptic plasticity and memory formation, but the
contribution to excitotoxicity by these two major NMDA receptor subtypes, NR2A and NR2B, has
remained enigmatic.
Both NR2A- and NR2B-type NMDA receptors activate signaling pathways that lead to LTP
formation (Köhr et al., 2003). The NR2B subunit predominates early in development and then
gradually decreases, whereas expression of NR2A is low shortly after birth but continues to increase.
Therefore, NR2B is the major subunit during the early period of a neuron’s life, whereas NR2A is
predominant in the later stages, suggesting that the NR2B to NR2A switch is responsible for the
transition of a synapse from a more plastic to a less plastic state. In young animals, both NR2A and
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NR2B contribute to LTP, whereas in adult animals, NR2A-mediated signaling is dominating (Köhr
et al., 2003). The importance of having the correct number and composition of NMDA receptor
subunits is demonstrated by genetic studies. Targeted disruption of the NR2A subunits produces
mice with a reduction in LTP and deficiences in some learning tests (Sakimura et al., 1995). The
contribution of the NR2B-type pathway to learning and memory was demonstrated in mice
overexpressing the NR2B subunit (Tang et al., 1999; Wong et al., 2002). Overexpression of the
NR2B subunit in the forebrain produces a so-called “smart mouse” that shows improved
performance on memory tasks and larger NMDA-mediated currents in the hippocampus. However, it
is not known if this is due to the overexpression of the NR2B subunits or due to an increased total
number of NMDA receptors.
The development of mutant mice provides further insights into the role of distinct NR2 subunits in
neurotoxicity. Morikawa (Morikawa et al., 1998) investigated the role of the NR2A and NR2B
subunits in brain ischemia using mutant mice deficient in NR2A and double mutants deficient in
NR2A and NR2B (Sakimura et al., 1995; Kiyama et al., 1998). NR2A deficiency results in a
pronounced reduction in infarct volume. Infarct volume in mice lacking both NR2A and NR2B was
not different compared to the infarct volume in NR2A deficiency alone. The authors suggested that
NR2A subunits play an important role in glutamate neurotoxicity. However, an alternative
suggestion is that the observed protective effect could also result from a reduced number of
functional NMDA receptors, as NR2A knock-out mice show decreased NMDA receptor channel
activity (Sakimura et al., 1995; Kiyama et al., 1998). Alternatives to knock-out mice are gene-
manipulated mice which express C-terminally truncated NR2 subunits. Most of these mice express
gateable receptors that are synaptically activated, but are defective in intracellular signaling and
synaptic localization.
The intracellular, C-terminal domains of the NR2 subunits have been shown to interact with putative
scaffolding proteins of the postsynaptic density, such as PSD-95 (Kornau et al., 1995, 1997; Kim et
al., 1996; Mueller et al., 1996; Niethammer et al., 1996; Kim and Huganir, 1999). This type of
interaction has been suggested to be critical for synaptic targeting, clustering and signal transduction.
The importance of the C-termini of NMDA receptor subunits is further emphasized by the NR2DC/DC
mice expressing truncated NR2 subunits (Sprengel et al., 1998), which phenotypically resemble the
respective knock-out mice.
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In order to investigate the contribution of the NR1/NR2A and NR1/NR2B NMDA receptor subtypes
to excitatory cell death, NMDA-induced toxicity experiments were performed using high-density
primary cortical cell cultures. This in vitro cell culture system simplifies the direct pharmacological
approach of the NR2A and NR2B subunits. By using NR2 subunit-specific antagonists, NMDA
receptors could be directly manipulated during relatively fast and reproducible excitotoxicity
experiments. The use of neuronal cultures from mice with impaired functions of the NR2 subunits
(NR2DC/DC mice) made it possible to study separately the involvement of NR2A and NR2B subtypes
during excitatory cell death.
Immunoblot analysis, using antibodies against distinct N-methyl-D-aspartic acid (NMDA) receptor
subunits, illustrated that the NR2A and NR2B subunit proteins have developmental profiles in
cultured cortical neurons similar to those seen in vivo (Li et al., 1998). NR1 and NR2B subunits
display high levels of expression within the first week. In contrast, the NR2A subunit is barely
detectable at 7 days in vitro (DIV) and then gradually increased to mature levels at 21 DIV.
Immunocytochemical analysis indicated that NMDA receptor subunits cluster in the dendrites and
soma of cortical neurons in culture (Li et al., 1998). Clusters of NR1 and NR2B subunits were
observed as early as 3 DIV, while NR2A clusters were rarely observed before 10 DIV. At 18 DIV,
NR2B clusters partially co-localize with those of NR2A subunits, but NR2B clusters always co-
localize with those of NR1 subunits.  Li’s studies indicate that excitatory synapse formation occurs
when NMDA receptors comprise NR1 and NR2B subunits, and that NR2A subunits cluster
preferentially at synaptic sites.
To accurate investigate the role of the two major NMDA receptor subtypes NR2A and NR2B to
excitatory cell death, all the NMDA-induced toxicity experiments were therefore in this study
performed in young (14 DIV) as well as in mature (21 DIV) cultures.
4.1.1 In NR2ADC/DC cultures excitotoxicity is mediated via NR1/NR2B containing NMDA
receptors
In the first set of experiments, NMDA-induced toxicity experiments were performed on cultures
prepared from NR2ADC/DC mice. By blocking NR2B subunits during NMDA application, it was
observed that young and mature neurons were entirely protected from NMDA-induced toxicity.
Discussion
60
Furthermore, 45Ca2+ analysis indicated that in the presence of a NR2B subunit-specific blocker, no
Ca2+ influx through NMDA receptor could be observed. These results suggest that in the NR2ADC/DC
cultures in which the function of the NR2A subunit is impaired, the NR2B subunit is the only key
mediator of Ca2+ influx and excitatory cell death.
Electrophysiological recordings indicated no change in the somatic and synaptic NMDA currents in
the NR2ADC/DC cultures compared to those recorded in wild-type sister cultures. Western blot
analysis proved furthermore that the NR2B subunit is expressed at normal levels, suggesting that the
C-terminal truncation of the NR2A subunit had no consequences on the expression level of the
NR2B subunit. Colocalization analysis of the immunoflourescently labeled NR2A subunit and the
synaptic marker protein Synapsin I indicated a reduction in the number of NR2A-containing
synapses in mature NR2ADC/DC cultures. This suggests that the C-terminal truncation of the NR2A
subunit led to an impaired synaptic localization of NMDA receptors containing the NR2A subunit.
These results are consistent with the data obtained by Steigerwald et al. (2000) analyzing the
function of the NR2ADC subunit in hippocampal slices and hippocampal cultures.
In hippocampal slices from adult wild-type mice, the NR2A subunit is primarily responsible for the
LTP induction at hippocampal CA1-to-CA3 synapses, independent of the used tetanization paradigm
(Köhr et al., 2003). However, in hippocampal slices from NR2ADC/DC mice, a lack in NR2A-
mediated LTP is observed; a strong LTP induction protocol leads to the formation of an exclusively
NR2B-mediated LTP. Excitotoxicity experiments performed on cultures prepared from NR2ADC/DC
mice were consistent with these LTP studies. When the intracellular pathway was eliminated by
removal of the C-terminal domain of the NR2A subunit, NR2B-type channels were the only
mediators of the signaling that access the “cell death program” pathway.
4.1.2 No NMDA-mediated excitatory cell death in neuronal NR2BDC/DC cultures
Studies on cultured neocortical neurons prepared from NR2BDC/DC mice indicated that the synaptic
NMDA receptor fraction is drastically reduced, suggesting that the C-terminal domain of the NR2B
subunit plays a major role in synaptic targeting of NMDA receptors at nascent synapses (Mohrmann
et al., 2002). Furtehrmore, the analyisis of the biophysical properties of NMDA receptor channels
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revealed a reduced peak open probability and a reduced mean open time in neurons from NR2BDC/DC
mice. This might reflect the loss of tonic modulation of NMDA receptor channels that is mediated by
protein phosphorylation of the C-terminal domain of NR2 subunits (Mohrmann et al., 2002).
It is particularly interesting to study the effect of the C-terminal truncation of the NR2B subunit in
excitotoxicity, since NR1/ NR2B receptors represent the “young” form of NMDA receptors in
immature synapses.
Therefore in a second set of experiments NMDA-induced toxicity experiments were performed on
cortical cultures prepared from NR2BDC/DC mice. Interestingly, cultured neurons from NR2BDC/DC
embryos showed a strong protection against NMDA-induced toxicity. 45Ca2+ analysis indicated no
Ca2+ influx through NMDA receptors in cultures prepared from NR2BDC/DC mice compared to wild-
type sister cultures. These results suggest that the NR2A subunit can not be part of any compensatory
mechanism contributing to excitatory cell death in cortical cultures in which the intracellular NR2B
subunit function is impaired by the truncation of the C-terminus.
Western blot analysis indicated a normal expression level of the NR2A subunit, comparable to those
observed in wild-type cultures. Electrophysiological recordings from nucleated patches showed
about one-third reduced somatic currents. Analysis of mEPSC recordings revealed that synaptic
currents are reduced one third compared to those recorded in wild-type sister cultures.
These results lead to the conclusion that the NR2A subunit is not able to compensate the functional
impairment of the NR2B subunit. Furthermore, when the NR2B subunit is expressed in the C-
terminal truncated form, the localization of the NR2A subunit is abolished at synaptic sites. As
indicated by the Western blot analysis, the NR2A subunit is expressed at a level comparable to that
observed in wild-type sister cultures; the subunit is transported to the cell membrane but it can not be
functionally integrated into synaptic sites.
4.1.3 In wild-type cultures excitotoxicity is mediated by NR2A and NR2B containing NMDA
receptors
The investigation of the contribution of NMDA receptors with different subunit compositions to
excitotoxicity has been difficult without the availability of pharmacological agents that can reliably
distinguish between the different NR2 subunits. The only ones available have been ifenprodil and
CP101606, two polyamine site antagonists. These antagonists are selective for the NR2B subunit.
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However, the recent introduction of NVP-AAM077, a NR2A selective antagonist, has allowed in this
study the further investigation of the role this major subunit plays in excitotoxicity. Recently that
have been published two studies, using the newly developed NR2A subunit specific antagonist, that
focus on the roles of NR2A- and NR2B-containing NMDA receptors in both LTP and LTD in slices
from adult and juvenile rats. The results of these two studies demonstrate that NR2A receptors are
involved in LTP and depotentiation while NR2B receptors are involved in formation of de novo LTD
(LTD induced at synapses that have not been previously altered experimentally) (Liu et al., 2004;
Massey et al., 2004).
In order to study the particular contribution of the NR2A and NR2B subtypes to NMDA-induced
excitotoxicity, a pharmacological approach was performed using cortical wild-type cultures.
Young cultures were protected from neuronal loss when the NR2B subunit-specific blockers
ifenprodil or CP-101606 was added during NMDA application. But when the NR2B subunits were
blocked by ifenprodil the mature wild-type cultures were vulnerable to NMDA mediated excitatory
cell death. These contrasting results can be explained by the different developmental expression
profile of the two subunits: in young cultures excitotoxicity is mediated mainly via receptors
containing at this stage NR2B subunit, as a dominant subtype. The higher expression level of the
NR2A-subunit in mature neurons leads to the vulnerability in the presence of the NR2B-specific
antagonist. These experiments lead to the conclusion that in mature cultures in the presence of a
NR2B-specific blocker NMDA toxicity is mediated via the NR2A-containing receptors.
As could be expected from the developmental expression profile of the NR2A subunit and the
previously described results, the application of a newly developed NR2A-specific antagonist called
NVP-AAM007 can not protect young neuronal cultures to NMDA-induced excitotoxicity. But
surprisingly the antagonist is also not able to prevent neuronal cell death in the mature cultures. Only
the combined application of a NR2A and a NR2B-specific antagonists can rescue the neurons at 21
DIV. Blocking any of the two subtypes is not reducing toxicity at a mature stage, due to the ability of
both subtypes, NR2A-containing or NR2B-containing NMDA receptors, to compensate with no
apparent time delay.
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4.2 NMDA receptor localization and excitotoxicity
Functional and immunocytochemical studies have shown that NMDA receptors are present at both
synaptic and extrasynaptic sites. It is possible that the extrasynaptic population simply represents
receptors that have been delivered to the plasma membrane and await incorporation into the synapse.
This idea is supported by recent work that shows that NMDARs can rapidly move between synaptic
and extrasynaptic sites, possibly by lateral diffusion of the receptor (Tovar and Westbrook, 2002).
However, the possibility remains that there is a distinct population of extrasynaptic receptors with a
specific function. Furthermore, synaptic and extrasynaptic receptor pools have different subunit
compositions and form distinct receptor populations: NR2A-containing NMDA receptors are mainly
localized at synaptic sites, whereas NR2B-containing NMDA receptors are mainly at extrasynaptic
sites (Tovar and Wesbrook, 1999).
Recent studies indicate that synaptic and extrasynaptic NMDA receptors have opposite effects on
CREB (cAMP response element binding protein) function, gene regulation and neuronal survival
(Hardingham et al., 2002). Ca2+ entry through synaptic NMDA receptors induces CREB activity and
BDNF (brain-derived neurotrophic factor) gene expression. In contrast, Ca2+ entry through
extrasynaptic NMDA receptors activates a dominant CREB shut-off pathway that blocks BDNF gene
expression and promotes neuronal cell death. The results obtained by Hardingham et al. actually
suggest that the NR2B NMDA receptor subtype, located extrasynaptically, is the main mediator of
the cell death pathway.
Neuronal cultures prepared from NR2BDC/DC embryos exhibited no vulnerability against NMDA-
mediated excitotoxicity. As indicated by Western blot analysis the NR2A subunit is expressed in
these cultures at levels comparable with those observed in wild-type neurons. Furthermore the
recordings of extrasynaptic currents prove that the NR2A subunits are transported to the cell surface
membrane and stay localized at extrasynaptic sites. This leads to the conclusion that the activation of
extrasynaptic NMDA receptors is not the main determinant for the induction of the neuronal cell
death program. These results are contradictory with the studies described by Hardingham et al. One
possible explanation is that all the investigations done by Hardingham et al. were performed in low-
density hippocampal cultures, at 10-12 days in vitro. By using relatively young neuronal cultures (14
DIV) we were also able to conclude that excitotoxicity is indeed mainly mediated via the NR2B
subunit, since neurons are not mature and express only low levels of the NR2A subunit. In addition
our results obtained from mature NR2ADC/DC cultures are consistent with the excitotoxicity seen in
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wild-type cultures, but, in contrast in the cultures with the C-terminally truncated form of the NR2A
subunit, NR2B-containing receptors are responsible for the neuronal cell death. Our data suggest that
in the NR2ADC/DC cultures, in which the function of the NR2A subunit is impaired, the NR2B subunit
localized at synaptic sites is the only mediator of Ca2+ influx and excitatory cell death.
4.3 Ca2+ influx, intracellular signaling and excitotoxicity
Ca2+ -mediated neurotoxicity requires distinct signaling pathways to be triggered in cells, and such
pathways are more efficiently triggered when Ca2+ ions enter neurons at specific entry points,
particularly at Ca2+ -permeable glutamate receptors (Timianski et al., 1993; Sattler et al., 1998). This
has been called the “source-specificity” hypothesis of Ca2+ neurotoxicity.
A previous study (Sattler et al., 1998) reveals that Ca2+ loading through L-type voltage-sensitive Ca2+
channels (VSCCs) is not harmful, whereas similar Ca2+ loads produced via NMDA receptors are
highly neurotoxic. The source-specificity hypothesis proposes that rate-limiting enzymes or
substrates responsible for excitotoxicity must be co-localized with NMDA receptors.
Current knowledge of the molecular organization of the PSD provides a blueprint for explaining the
toxicity of Ca2+ ions that enter neurons through NMDA receptors. It suggests that NMDA receptor-
mediated Ca2+ signals are linked to downstream neurotoxic signaling pathways through protein-
protein interactions.
Recent studies show that by suppressing the expression of PSD-95 in cultured cortical neurons using
antisense oligonucleotides, the function of NMDA receptors is not altered and the receptor
expression, NMDA currents and Ca2+ loading via NMDA receptors are unchanged (Sattler et al.,
1999). However, suppressing PSD-95 selectively attenuated Ca2+-activated NO (nitric oxide)
production by NMDA receptors. The authors conclude that PSD-95 is required for the efficient
coupling of NMDA receptor activity to NO toxicity, and imparts specificity to NMDA receptor-
mediated excitotoxic Ca2+ signaling.
In the present study, no specific experiments were performed to investigate any component of the
intracellular signaling pathway. But by using cultures prepared from NR2DC/DC mice it was possible
to study the importance of the C-termini of NR2A and NR2B to Ca2+ influx and excitatory cell death.
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Cultures prepared from NR2BDC/DC mice were resistant against NMDA-induced excitotoxicity, and
no obvious Ca2+ influx could be measured. In contrast, in NR2ADC/DC cultures Ca2+ influx and
NMDA-induced neuronal loss were similar with wild-type cultures. These results indicate that in the
absence of functional NR2A subunits, the NR2B subtype is able to compensate and mediate Ca2+
influx alone, thereby inducing the cell death pathway. However, when NR2B subunit function is
impaired, the NR2A subtype is not able to participate in any compensatory mechanism and Ca2+
influx is occluded. Electrophysiological recordings indicated reduced extrasynaptic currents in
NR2BDC/DC cultures. These results do not exclude that in the NR2BDC/DC cultures a very low Ca2+
influx through extrasynaptic NMDA receptors occurs, but these concentrations are to small to be
detected with the 45Ca2+ assay. The amount of Ca2+ ions that enter the cells is not sufficient to trigger
the cell death cascade.
4.4 From molecular interactions to clinical treatments
The idea that the NMDA receptor/PSD-95 interaction might constitute a therapeutic target for
diseases that involve excitotoxicity was recently investigated (Aarts et al., 2002). This concept is
illustrating the importance of intracellular interactions between the C-terminus of NR2 subunits with
other proteins. NMDA receptors mediate ischaemic brain damage, but their main function is the
transmission of neuronal excitation, which is essential for normal CNS function. Thus, blocking
NMDA receptors in order to treat stroke is problematic. Targeting PSD-95 protein therefore
represents an alternative therapeutic approach that may circumvent the negative consequences of
blocking NMDA receptor function. However, mutation or suppression of PSD-95 is impractical as a
therapy for brain injury and can not be applied after an injury has occurred.
The question was whether interfering with the NMDA receptor/PSD-95 interaction rather than
altering PSD-95 expression would be a better approach in order to suppress excitotoxicity in vitro
and ischemic brain damage in vivo. To treat stroke without blocking NMDA receptors, neurons in
vitro and in vivo are transfected with peptides that bind to the modular domains governing
interactions of NMDA receptors with PSD-95. The peptide treatment protects cultured neurons from
excitotoxicity. In addition it reduces dramatically cerebral infarction in rats subjected to transient
focal cerebral ischemia, while improving neurological functions. The treatment is effective when
applied either before, or one hour after, the onset of excitotoxicity in vitro and cerebral ischemia in
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vivo (Aarts et al., 2002). This and similar strategies based on a molecular understanding of
excitotoxic mechanisms may amount to practical future treatments for human neurological disorders.
4.5 NMDA subunits antagonits and clinical trials
Among CNS disorders, the preclinical rationale for the acute treatment of brain ischemia is the
strongest (Kemp et al., 1999), and nonselective NMDA antagonists are the most consistently
neuroprotective agents in animal models of stroke. Nevertheless, clinical trials in stroke and
traumatic brain injury with NMDA antagonists have failed so far (Kemp et al., 1999; Lees et al.,
2000; Sacco et al., 2001). NMDA antagonists have a number of adverse CNS effects, including
hallucinations, a centrally mediated increase in blood pressure and, at high doses, catatonia and
anesthesia (for which the NMDA channel blockers phencyclidine and ketamine were initially
developed).
Subtype selective compounds of those with improved biochemical mechanisms are further being
developed and studied. A number of selective NR2B subunit antagonists have been described, most
of which are neuroprotective in animal models and produce minimal side effects at maximally
neuroptotective doses (for example ifenprodil, CP-101606, Ro 25-6981 and Ro 63-1908).
Encouragingly, in humans, CP-101606 did not induce the usual side effects seen with nonselective
NMDA antagonists. However, enthusiasm for this approach has been tempered by its reported failure
in a clinical trial of traumatic brain injury (press release from Pfitzer, October 2001).
There is big hope for further trials with different compounds, and the new NR2A subunit antagonist
NVP-AAM077 has recently been developed by Novartis Pharma (AG, Switzerland). In the present
study, this NR2A subunit specific antagonist showed no protective effect to NMDA-induced
excitotoxicity using mouse cortical cell cultures. Blocking any of the two NR2 subtypes did not
reduce excitotoxicity in a mature neuronal culture system, due to the ability of both studied NR2
subunits to compensate for the functional loss of NMDA receptors with the other subunit without
apparent time delay.
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4.6 Ischemia – still a challenge
The past decade has produced a plethora of negative neuroprotective trial results. This is frustrating
because all of these agents seemed effective in animal trials. The ischemic cascade appears to be so
complex that targeting a single pathway may be ineffective.
A "good" in vivo animal model of stroke must reproduce the etiology, anatomical, functional and
metabolic consequences of human pathology and must also permit the study of anti-ischemic drugs
in conditions pertinent to the clinical therapeutics. As stroke is a very heterogeneous clinical entity,
such a model could only mimic a limited part of stroke. Animal data are usually collected in healthy
laboratory rodents of the same age, in which a standardized amount of cerebral ischemia is induced
by a reproducible intervention. In contrast, aetiology, location and severity of ischaemic stroke in
patients is very heterogeneous.
A large number of compounds have been shown to be active using animal models, but unfortunately,
none of them was found to be active in clinical trials. Various factors could be responsible for this
major discrepancy, and some of them are not related to pre-clinical studies, but to the complexities of
the clinical problem of stroke. Failure in the translation of results from animal models to humans
implicates potential limitations of the current drug development process. Retrospective analysis of
studies suggests possible improvements at several stages during pre-clinical studies.
Standardized guidelines for preclinical evaluation of neuroprotective drugs may improve chances of
success.
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5. Abbreviations
a Alpha
A Ampere
ACPD aminocyclopentane-1S, 3R-dicarboxylic acid, mGluR agonist
AMP adenosine monophosphate
AMPA                L-a-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid
AMPAR AMPA receptor
D-AP5 D-5-amino phosphonate pentanoic acid
ARL 15896 [(+)-alpha-phenyl-2-pyridineethanamine], NMDAR channel antagonist
ATP adenosine triphosphate
BAPTA 1,2-bis-(2-aminophenoxy)ethane-N,N,N’,N’-tetracacetic acid
BDNF brain-derived neurotrophic factor
BMI bicuculline methiodide
BSA bovine serum albumin
bp baise pairs
C Celsius
CA Cornu ammonis
CaMKII Ca2+/calmodulin-dependent proteinkinase II
cDNA copy DNA
CNS central nervous system
CNQX 6-Cyano-7-nitroquinoxaline-2,3-dione, AMPA antagonist
D Delta
DIV days in vitro
DNA deoxyribonucleic acid
dNTPs deoxyribonucleotides
IC50 concentration required for half maximal response
EDTA Ethylene diaminetetraacetic acid
EGTA Ethylene glycol-bis(2-aminoethyl)-N,N,N’,N’-tetraacetic acid
EPSC excitatory postsynaptic current
et al. et alii
Fig. Figure
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FITC Fluorescein isothiocyanate
G-protein guanosine nucleotide-binding protein
GABA g-Aminobutiric acid
g gamma
GluR glutamate receptor
GTP guanosine triphosphate
h hour
HCSS HEPES-buffered control salt solution
HEPES N-(2-Hydroxyethyl)piperazine-N’-ethanesulfonic acid
IPSP inhibitory postsynaptic current
KA kainate
LTD long-term depression
LTP long term potentiation
m micro
m milli
m miniature
M membrane (domain)
M Mol
mGluR metabotropic glutamate receptor
min minute
mRNA messenger RNA
MS-153 [R]-[-]-5-methyl-1-nicotinoyl-2-pyrazoline, NMDAR antagonist
n nano
n number (of experiments, animals, etc.)
N asparagine
NMDA N-methyl-D-aspartate
NMDAR NMDA receptor
NBQX 2,3-dihidroxy-6-nitro-7-sulfmoyl-benzo-(F)-quinoxalone
NO nitric oxide
NOS nitric oxide synthase
NR1 NMDAR subunit 1
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NR1-1a NMDAR subunit 1 splice variant 1a
NR2A/B/C NMDAR subunit 2A/B/C
NR3A/B NMDAR subunit 3A/B
NTD N-terminal domain
NVP-AAM077 (1RS,1'S)-PEAQX, NR2A subunit specific antagonist
W Ohm
Osm Osmol
% percentage
p pico
p probability
P postnatal
PBS phosphate buffered saline
PCR polymerase chain reaction
PDZ PSD-95, Disc-large, Zona-occludens-1, proteins in which PDZ
domains were originally identified
PFA paraformaldehyde
PKA cyclic AMP-dependent protein kinase A
PKC protein kinase C
PSD postsynaptic density
Q glutamine
R arginine
RNA ribonucleic acid
s second
S segment
S serine
S Siemens
SDS-PAGE SDS-PolyAcrylamide Gel Electrophoresis
SDS sodium dodecylsulfate
SEM standard error of the mean
STDEV Standard deviation
Taq Therminus aquaticus
Tris Tris(hydroxymethyl)aminomethan
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TTX tetrodoxin
U unit
V voltage
V volts
VDCCs voltage-dependent calcium channels
vs versus
W Watt
wt wild-type
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